Document_and_Entity_Informatio
Document and Entity Information | 3 Months Ended | |
Dec. 31, 2014 | Jan. 30, 2015 | |
Document and Entity Information | ||
Entity Registrant Name | Sally Beauty Holdings, Inc. | |
Entity Central Index Key | 1368458 | |
Document Type | 10-Q | |
Document Period End Date | 31-Dec-14 | |
Amendment Flag | FALSE | |
Current Fiscal Year End Date | -21 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Large Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 158,343,373 | |
Document Fiscal Year Focus | 2015 | |
Document Fiscal Period Focus | Q1 |
Consolidated_Statements_of_Ear
Consolidated Statements of Earnings (USD $) | 3 Months Ended | |
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Consolidated Statements of Earnings | ||
Net sales | $964,468 | $940,464 |
Cost of products sold and distribution expenses | 490,699 | 479,938 |
Gross profit | 473,769 | 460,526 |
Selling, general and administrative expenses | 336,954 | 319,478 |
Depreciation and amortization | 20,579 | 19,255 |
Operating earnings | 116,236 | 121,793 |
Interest expense | 29,241 | 28,489 |
Earnings before provision for income taxes | 86,995 | 93,304 |
Provision for income taxes | 32,086 | 35,309 |
Net earnings | $54,909 | $57,995 |
Earnings per share: | ||
Basic (in dollars per share) | $0.35 | $0.35 |
Diluted (in dollars per share) | $0.35 | $0.35 |
Weighted average shares: | ||
Basic (in shares) | 156,104 | 163,603 |
Diluted (in shares) | 158,545 | 167,755 |
Consolidated_Statements_of_Com
Consolidated Statements of Comprehensive Income (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Consolidated Statements of Comprehensive Income | ||
Net earnings | $54,909 | $57,995 |
Other comprehensive (loss) income: | ||
Foreign currency translation adjustments | -17,301 | 2,567 |
Total other comprehensive (loss) income, before tax | -17,301 | 2,567 |
Other comprehensive (loss) income, net of tax | -17,301 | 2,567 |
Total comprehensive income | $37,608 | $60,562 |
Consolidated_Balance_Sheets
Consolidated Balance Sheets (USD $) | Dec. 31, 2014 | Sep. 30, 2014 |
In Thousands, unless otherwise specified | ||
Current assets: | ||
Cash and cash equivalents | $190,681 | $106,575 |
Trade accounts receivable, less allowance for doubtful accounts of $1,983 at December 31, 2014 and $1,752 at September 30, 2014 | 46,916 | 51,797 |
Accounts receivable, other | 40,735 | 46,703 |
Inventory | 837,822 | 828,429 |
Other current assets | 35,868 | 38,995 |
Deferred income tax assets, net | 31,746 | 31,650 |
Total current assets | 1,183,768 | 1,104,149 |
Property and equipment, net of accumulated depreciation of $419,466 at December 31, 2014 and $413,208 at September 30, 2014 | 236,678 | 238,111 |
Goodwill | 531,412 | 536,341 |
Intangible assets, excluding goodwill, net of accumulated amortization of $89,887 at December 31, 2014 and $86,320 at September 30, 2014 | 109,589 | 114,744 |
Other assets | 35,587 | 36,628 |
Total assets | 2,097,034 | 2,029,973 |
Current liabilities: | ||
Current maturities of long-term debt | 888 | 974 |
Accounts payable | 264,773 | 259,463 |
Accrued liabilities | 160,630 | 198,769 |
Income taxes payable | 3,724 | 4,331 |
Total current liabilities | 430,015 | 463,537 |
Long-term debt | 1,810,104 | 1,810,667 |
Other liabilities | 28,903 | 27,848 |
Deferred income tax liabilities, net | 83,568 | 74,974 |
Total liabilities | 2,352,590 | 2,377,026 |
Stockholders' deficit: | ||
Common stock, $0.01 par value. Authorized 500,000 shares; 158,324 and 155,104 shares issued and 157,757 and 154,668 shares outstanding at December 31, 2014 and September 30, 2014, respectively | 1,578 | 1,547 |
Preferred stock, $0.01 par value. Authorized 50,000 shares; none issued | ||
Accumulated deficit | -211,285 | -320,052 |
Accumulated other comprehensive loss, net of tax | -45,849 | -28,548 |
Total stockholders' deficit | -255,556 | -347,053 |
Total liabilities and stockholders' deficit | $2,097,034 | $2,029,973 |
Consolidated_Balance_Sheets_Pa
Consolidated Balance Sheets (Parenthetical) (USD $) | Dec. 31, 2014 | Sep. 30, 2014 |
In Thousands, except Per Share data, unless otherwise specified | ||
Consolidated Balance Sheets | ||
Trade accounts receivable, allowance for doubtful accounts (in dollars) | $1,983 | $1,752 |
Property and equipment, accumulated depreciation (in dollars) | 419,466 | 413,208 |
Intangible assets, excluding goodwill, accumulated amortization (in dollars) | $89,887 | $86,320 |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, Authorized shares | 500,000 | 500,000 |
Common stock, shares issued | 158,324 | 155,104 |
Common stock, shares outstanding | 157,757 | 154,668 |
Preferred stock, par value (in dollars per share) | $0.01 | $0.01 |
Preferred stock, Authorized shares | 50,000 | 50,000 |
Preferred stock, shares issued | 0 | 0 |
Consolidated_Statements_of_Cas
Consolidated Statements of Cash Flows (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Cash Flows from Operating Activities: | ||
Net earnings | $54,909 | $57,995 |
Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
Depreciation and amortization | 20,579 | 19,255 |
Share-based compensation expense | 7,760 | 8,522 |
Amortization of deferred financing costs | 950 | 921 |
Excess tax benefit from share-based compensation | -17,043 | -2,985 |
Deferred income taxes | 8,341 | -563 |
Changes in (exclusive of effects of acquisitions): | ||
Trade accounts receivable | 3,944 | 4,537 |
Accounts receivable, other | 5,532 | -754 |
Inventory | -17,616 | -4,984 |
Other current assets | 19,943 | 2,948 |
Other assets | -572 | -160 |
Accounts payable and accrued liabilities | -30,363 | -57,259 |
Income taxes payable | -497 | 29,057 |
Other liabilities | 1,169 | 3,574 |
Net cash provided by operating activities | 57,036 | 60,104 |
Cash Flows from Investing Activities: | ||
Capital expenditures | -18,800 | -13,375 |
Net cash used by investing activities | -18,800 | -13,375 |
Cash Flows from Financing Activities: | ||
Proceeds from issuances of long-term debt | 232,719 | |
Repayments of long-term debt | -258 | -109,025 |
Repurchases of common stock | -7,253 | -66,183 |
Debt issuance costs | -3,888 | |
Proceeds from exercises of stock options | 37,156 | 7,319 |
Excess tax benefit from share-based compensation | 17,043 | 2,985 |
Net cash provided by financing activities | 46,688 | 63,927 |
Effect of foreign exchange rate changes on cash and cash equivalents | -818 | 153 |
Net increase in cash and cash equivalents | 84,106 | 110,809 |
Cash and cash equivalents, beginning of period | 106,575 | 47,115 |
Cash and cash equivalents, end of period | 190,681 | 157,924 |
Supplemental Cash Flow Information: | ||
Interest paid | 56,138 | 50,807 |
Income taxes paid | $4,835 | $4,119 |
Description_of_Business_and_Ba
Description of Business and Basis of Presentation | 3 Months Ended |
Dec. 31, 2014 | |
Description of Business and Basis of Presentation | |
Description of Business and Basis of Presentation | |
1. Description of Business and Basis of Presentation | |
Description of Business | |
Sally Beauty Holdings, Inc. and its consolidated subsidiaries (“Sally Beauty” or “the Company”) sell professional beauty supplies through its Sally Beauty Supply retail stores primarily in the U.S., Puerto Rico, Canada, Mexico, Chile, Peru, the United Kingdom, Ireland, Belgium, France, Germany, the Netherlands and Spain. Additionally, the Company distributes professional beauty products to salons and salon professionals through its Beauty Systems Group (“BSG”) store operations and a commissioned direct sales force that calls on salons primarily in the U.S., Puerto Rico, Canada, the United Kingdom and certain other countries in Europe, and to franchises in the southern and southwestern regions of the U.S., and in Mexico through the operations of its subsidiary Armstrong McCall, L.P. (“Armstrong McCall”). Certain beauty products sold by BSG and Armstrong McCall are sold under exclusive territory agreements with the manufacturers of the products. | |
Basis of Presentation | |
The accompanying consolidated interim financial statements include the accounts of the Company and its subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. In the opinion of management, these consolidated financial statements reflect all adjustments which are of a normal recurring nature and which are necessary to present fairly the Company’s consolidated financial position as of December 31, 2014 and September 30, 2014, and its consolidated results of operations and consolidated cash flows for the three months ended December 31, 2014 and 2013. | |
Certain amounts for prior fiscal periods have been reclassified to conform to the current fiscal period’s presentation. | |
All references in these notes to “management” are to the management of Sally Beauty. | |
Significant_Accounting_Policie
Significant Accounting Policies | 3 Months Ended |
Dec. 31, 2014 | |
Significant Accounting Policies | |
Significant Accounting Policies | |
2. Significant Accounting Policies | |
The consolidated interim financial statements included herein are unaudited and have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. These consolidated interim financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2014. The Company adheres to the same accounting policies in the preparation of its interim financial statements. As permitted under GAAP, interim accounting for certain expenses, including income taxes, is based on full year assumptions. Such amounts are expensed in full in the year incurred. For interim financial reporting purposes, income taxes are recorded based upon estimated annual effective income tax rates. | |
The results of operations for the interim periods reported upon herein are not necessarily indicative of the results that may be expected for any future interim period or the entire fiscal year. | |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 3 Months Ended |
Dec. 31, 2014 | |
Recent Accounting Pronouncements | |
Recent Accounting Pronouncements | |
3. Recent Accounting Pronouncements | |
We have not yet adopted and are currently assessing the potential effect of the following pronouncement on our consolidated financial statements: | |
In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”) which will supersede Accounting Standards Codification (“ASC”) Topic 605, Revenue Recognition. A core principle of the new guidance is that an entity should measure revenue in connection with its sale of goods and services to a customer based on an amount that depicts the consideration to which the entity expects to be entitled in exchange for each of those goods and services. For a contract that involves more than one performance obligation, the entity must (a) determine or, if necessary, estimate the standalone selling price at inception of the contract for the distinct goods or services underlying each performance obligation and (b) allocate the transaction price to each performance obligation on the basis of the relative standalone selling prices. In addition, under the new guidance, an entity should recognize revenue when (or as) it satisfies each performance obligation under the contract by transferring the promised good or service to the customer. A good or service is deemed transferred when (or as) the customer obtains control of that good or service. The new standard permits the use of either the retrospective or cumulative effect transition method. For public companies, this amendment is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early application is not permitted for public companies. The Company has not yet selected a transition method nor determined the effect of the new standard on its financial statements. | |
Fair_Value_Measurements
Fair Value Measurements | 3 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Fair Value Measurements | |||||||||||||
Fair Value Measurements | |||||||||||||
4. Fair Value Measurements | |||||||||||||
The Company’s financial instruments consist of cash equivalents, trade and other accounts receivable, accounts payable, foreign currency derivative instruments and debt. The carrying amounts of cash equivalents, trade and other accounts receivable and accounts payable approximate their respective fair values due to the short-term nature of these financial instruments. | |||||||||||||
The Company measures on a recurring basis and discloses the fair value of its financial instruments under the provisions of ASC Topic 820, Fair Value Measurement, as amended (“ASC 820”). The Company defines “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. This valuation hierarchy is based upon the transparency of inputs to the valuation of an asset or liability on the measurement date. The three levels of that hierarchy are defined as follows: | |||||||||||||
Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities; | |||||||||||||
Level 2 - Unadjusted quoted prices in active markets for similar assets or liabilities; or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active; or inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data; and | |||||||||||||
Level 3 - Unobservable inputs for the asset or liability. | |||||||||||||
Consistent with this hierarchy, the Company categorized certain of its financial assets and liabilities as follows at December 31, 2014 and September 30, 2014 (in thousands): | |||||||||||||
As of December 31, 2014 | |||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||
Assets | |||||||||||||
Cash equivalents (a) | $ | 107,501 | $ | 107,501 | $ | — | — | ||||||
Foreign exchange contracts (b) | 1,284 | — | 1,284 | — | |||||||||
Total assets | $ | 108,785 | $ | 107,501 | $ | 1,284 | — | ||||||
Liabilities | |||||||||||||
Long-term debt (c) | $ | 1,893,779 | $ | 1,890,000 | $ | 3,779 | — | ||||||
Foreign exchange contracts (b) | 3 | — | 3 | — | |||||||||
Total liabilities | $ | 1,893,782 | $ | 1,890,000 | $ | 3,782 | — | ||||||
As of September 30, 2014 | |||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||
Assets | |||||||||||||
Cash equivalents (a) | $ | 27,000 | $ | 27,000 | $ | — | — | ||||||
Foreign exchange contracts (b) | 511 | — | 511 | — | |||||||||
Total assets | $ | 27,511 | $ | 27,000 | $ | 511 | — | ||||||
Liabilities | |||||||||||||
Long-term debt (c) | $ | 1,874,444 | $ | 1,870,250 | $ | 4,194 | — | ||||||
Foreign exchange contracts (b) | 47 | — | 47 | — | |||||||||
Total liabilities | $ | 1,874,491 | $ | 1,870,250 | $ | 4,241 | — | ||||||
(a) | Cash equivalents consist of highly liquid investments which have no maturity and are valued using unadjusted quoted market prices for such securities. The Company may from time to time invest in securities with maturities of three months or less (consisting primarily of investment-grade corporate and government bonds), with the primary investment objective of minimizing the potential risk of loss of principal. | ||||||||||||
(b) | Foreign exchange contracts (including foreign currency forwards and options) are valued for purposes of this disclosure using widely accepted valuation techniques, such as discounted cash flow analyses, and reasonable estimates, such as market foreign currency exchange rates. Please see Note 10 for more information about the Company’s foreign exchange contracts. | ||||||||||||
(c) | Long-term debt (including current maturities and borrowings under the ABL facility, if any) is carried in the Company’s consolidated financial statements at amortized cost of $1,811.0 million at December 31, 2014 and $1,811.6 million at September 30, 2014. The Company’s senior notes are valued for purposes of this disclosure using unadjusted quoted market prices for such debt securities. Other long-term debt (consisting primarily of borrowings under the ABL facility, if any, and capital lease obligations) is generally valued for purposes of this disclosure using widely accepted valuation techniques, such as discounted cash flow analyses, and observable inputs, such as market interest rates. Please see Note 9 for more information about the Company’s debt. | ||||||||||||
Accumulated_Stockholders_Equit
Accumulated Stockholders' Equity (Deficit) | 3 Months Ended |
Dec. 31, 2014 | |
Accumulated Stockholders' Equity (Deficit) | |
Accumulated Stockholders' Equity (Deficit) | |
5. Accumulated Stockholders’ Equity (Deficit) | |
In August 2014, we announced that our Board of Directors approved a share repurchase program authorizing us to repurchase up to $1.0 billion of our common stock over a period of approximately three years (the “2014 Share Repurchase Program”). The 2014 Share Repurchase Program expires on September 30, 2017. | |
During the three months ended December 31, 2014, the Company repurchased and subsequently retired approximately 0.2 million shares of its common stock under the 2014 Share Repurchase Program at an aggregate cost of $7.3 million. In addition, during the three months ended December 31, 2013, the Company repurchased and subsequently retired approximately 2.4 million shares of its common stock under the 2013 Share Repurchase Program (a share repurchase program approved by our Board in March 2013 and terminated in connection with the authorization of the 2014 Share Repurchase Program) at an aggregate cost of $66.2 million. The Company reduced common stock and additional paid-in capital, in the aggregate, by these amounts. As required by GAAP, the Company recorded any amounts paid to repurchase shares in excess of the balance of additional paid-in capital in accumulated deficit. | |
At December 31, 2014 and September 30, 2014, accumulated other comprehensive loss consists of cumulative foreign currency translation adjustments of $45.8 million and $28.5 million, respectively, net of income taxes of $2.3 million at both dates. Comprehensive income (loss) reflects changes in accumulated stockholders’ equity (deficit) from sources other than transactions with stockholders and, as such, includes net earnings and certain other specified components. Currently, the Company’s only component of comprehensive income, other than net earnings, is foreign currency translation adjustments, net of income tax. | |
Earnings_Per_Share
Earnings Per Share | 3 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Earnings Per Share | ||||||||
Earnings Per Share | ||||||||
6. Earnings Per Share | ||||||||
Basic earnings per share, is calculated by dividing net earnings by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is calculated similarly but includes the potential dilution from the exercise of all outstanding stock options and stock awards, except when the effect would be anti-dilutive. | ||||||||
The following table sets forth the computations of basic and diluted earnings per share (in thousands, except per share data): | ||||||||
Three Months Ended | ||||||||
December 31, | ||||||||
2014 | 2013 | |||||||
Net earnings | $ | 54,909 | $ | 57,995 | ||||
Weighted average basic shares | 156,104 | 163,603 | ||||||
Dilutive securities: | ||||||||
Stock option and stock award programs | 2,441 | 4,152 | ||||||
Weighted average diluted shares | 158,545 | 167,755 | ||||||
Earnings per share: | ||||||||
Basic | $ | 0.35 | $ | 0.35 | ||||
Diluted | $ | 0.35 | $ | 0.35 | ||||
At December 31, 2014 and 2013, options to purchase 1,259,204 shares and 1,462,543 shares, respectively, of the Company’s common stock were outstanding but not included in the computations of diluted earnings per share since these options were anti-dilutive. Anti-dilutive options are: (a) out-of-the-money options (options the exercise price of which is greater than the average price per share of the Company’s common stock during the period), and (b) in-the-money options (options the exercise price of which is less than the average price per share of the Company’s common stock during the period) for which the sum of assumed proceeds, including any unrecognized compensation expense related to such options, exceeds the average price per share for the period. | ||||||||
ShareBased_Payments
Share-Based Payments | 3 Months Ended | |||||||||||||
Dec. 31, 2014 | ||||||||||||||
Share-Based Payments | ||||||||||||||
Share-Based Payments | ||||||||||||||
7. Share-Based Payments | ||||||||||||||
The Company measures the cost of services received from employees, directors and consultants in exchange for an award of equity instruments based on the fair value of the award on the date of grant, and recognizes compensation expense on a straight-line basis over the vesting period or over the period ending on the date a participant becomes eligible for retirement, if earlier. | ||||||||||||||
The Company granted approximately 1.1 million and 1.5 million stock options and approximately 214,000 and 25,000 restricted share awards to its employees and consultants during the three months ended December 31, 2014 and 2013, respectively. Upon issuance of such grants, the Company recognized accelerated share-based compensation expense of $4.8 million and $5.3 million in the three months ended December 31, 2014 and 2013, respectively, in connection with certain retirement eligible employees who are eligible to continue vesting awards upon retirement under the provisions of the Sally Beauty Holdings, Inc. Amended and Restated 2010 Omnibus Incentive Plan (the “2010 Plan”). In addition, the Company granted approximately 20,000 and 27,000 restricted stock units to its non-employee directors during the three months ended December 31, 2014 and 2013, respectively. | ||||||||||||||
The following table presents the total compensation cost charged against income and included in selling, general and administrative expenses for all share-based compensation arrangements and the related tax benefits recognized in our consolidated statements of earnings (in thousands): | ||||||||||||||
Three Months Ended | ||||||||||||||
December 31, | ||||||||||||||
2014 | 2013 | |||||||||||||
Share-based compensation expense | $ | 7,760 | $ | 8,522 | ||||||||||
Income tax benefit related to share-based compensation expense | $ | 2,918 | $ | 3,181 | ||||||||||
Stock Option Awards | ||||||||||||||
Each option has an exercise price equal to the closing market price of the Company’s common stock on the date of grant and generally has a maximum term of 10 years. Options generally vest ratably over a four year period and are generally subject to forfeiture until the vesting period is complete, subject to certain retirement provisions contained in the 2010 Plan and certain predecessor share-based compensation plans such as the Sally Beauty Holdings, Inc. 2007 Omnibus Incentive Plan. | ||||||||||||||
The following table presents a summary of the activity for the Company’s stock option awards for the three months ended December 31, 2014: | ||||||||||||||
Number of | Weighted | Weighted | Aggregate | |||||||||||
Outstanding | Average | Average | Intrinsic | |||||||||||
Options (in | Exercise | Remaining | Value (in | |||||||||||
Thousands) | Price | Contractual | Thousands) | |||||||||||
Term (in | ||||||||||||||
Years) | ||||||||||||||
Outstanding at September 30, 2014 | 8,983 | $ | 15.93 | 6.2 | $ | 102,751 | ||||||||
Granted | 1,132 | 29.2 | ||||||||||||
Exercised | (3,265 | ) | 11.38 | |||||||||||
Forfeited or expired | (33 | ) | 22.64 | |||||||||||
Outstanding at December 31, 2014 | 6,817 | $ | 20.28 | 7.1 | $ | 71,282 | ||||||||
Exercisable at December 31, 2014 | 3,405 | $ | 14.78 | 5.5 | $ | 54,366 | ||||||||
The following table summarizes additional information about stock options outstanding under the Company’s share-based compensation plans: | ||||||||||||||
Options Outstanding | Options Exercisable | |||||||||||||
Range of | Number | Weighted | Weighted | Number | Weighted | |||||||||
Exercise Prices | Outstanding at | Average | Average | Exercisable at | Average | |||||||||
December 31, | Remaining | Exercise | December 31, | Exercise | ||||||||||
2014 (in | Contractual | Price | 2014 (in | Price | ||||||||||
Thousands) | Term (in | Thousands) | ||||||||||||
Years) | ||||||||||||||
$2.00 — 19.99 | 3,026 | 5.0 | $ | 12.79 | 2,617 | $ | 11.78 | |||||||
$20.00 — 29.20 | 3,791 | 8.7 | 26.27 | 788 | 24.70 | |||||||||
Total | 6,817 | 7.1 | $ | 20.28 | 3,405 | $ | 14.78 | |||||||
The Company uses the Black-Scholes option pricing model to value the Company’s stock options for each stock option award. Using this option pricing model, the fair value of each stock option award is estimated on the date of grant. The fair value of the Company’s stock option awards is expensed on a straight-line basis over the vesting period (generally four years) of the stock options or to the date a participant becomes eligible for retirement, if earlier. | ||||||||||||||
The weighted average assumptions relating to the valuation of the Company’s stock options are as follows: | ||||||||||||||
Three months ended | ||||||||||||||
December 31, | ||||||||||||||
2014 | 2013 | |||||||||||||
Expected life (in years) | 5.0 | 5.0 | ||||||||||||
Expected volatility for the Company’s stock | 31.0 | % | 48.4 | % | ||||||||||
Risk-free interest rate | 1.6 | % | 1.3 | % | ||||||||||
Dividend yield | 0.0 | % | 0.0 | % | ||||||||||
The expected life of options represents the period of time that the options granted are expected to be outstanding and is based on historical experience of employees of the Company who have been granted stock options. The risk-free interest rate is based on the zero-coupon U.S. Treasury notes with a comparable term as of the date of the grant. Since the Company does not currently expect to pay dividends, the dividend yield used is 0%. | ||||||||||||||
The weighted average fair value at the date of grant of the stock options issued by the Company in the three months ended December 31, 2014 and 2013 was $8.77 and $11.32 per option, respectively. The total intrinsic value of options exercised during the three months ended December 31, 2014 was $61.5 million. The cash proceeds from these option exercises were $37.2 million and the tax benefit realized from these option exercises was $23.4 million. | ||||||||||||||
At December 31, 2014, unrecognized compensation costs related to unvested stock option awards are approximately $18.0 million and are expected to be recognized over the weighted average period of 2.6 years. | ||||||||||||||
Stock Awards | ||||||||||||||
Restricted Stock Awards | ||||||||||||||
The Company from time to time grants restricted stock awards to employees and consultants under the 2010 Plan. A restricted stock award is an award of shares of the Company’s common stock (which have full voting and dividend rights but are restricted with regard to sale or transfer) the restrictions over which lapse ratably over a specified period of time (generally four to five years). Restricted stock awards are independent of stock option grants and are generally subject to forfeiture if employment terminates prior to these restrictions lapsing, subject to certain retirement provisions of the 2010 Plan. | ||||||||||||||
The fair value of the Company’s restricted stock awards is expensed on a straight-line basis over the period (generally four to five years) in which the restrictions on these stock awards lapse (“vesting”) or over the period ending on the date a participant becomes eligible for retirement, if earlier. For these purposes, the fair value of the restricted stock award is determined based on the closing market price of the Company’s common stock on the date of grant. | ||||||||||||||
The following table presents a summary of the activity for the Company’s restricted stock awards for the three months ended December 31, 2014: | ||||||||||||||
Restricted Stock Awards | Number of Shares | Weighted Average | Weighted Average | |||||||||||
(in Thousands) | Fair Value Per | Remaining | ||||||||||||
Share | Vesting Term (in | |||||||||||||
Years) | ||||||||||||||
Unvested at September 30, 2014 | 436 | $ | 22.42 | 3.4 | ||||||||||
Granted | 214 | 29.2 | ||||||||||||
Vested | (83 | ) | 14.3 | |||||||||||
Forfeited | — | — | ||||||||||||
Unvested at December 31, 2014 | 567 | $ | 26.16 | 3.2 | ||||||||||
At December 31, 2014, unrecognized compensation costs related to unvested restricted stock awards are approximately $6.8 million and are expected to be recognized over the weighted average period of 3.2 years. | ||||||||||||||
Restricted Stock Units | ||||||||||||||
The Company currently grants Restricted Stock Unit (“RSU” or “RSUs”) awards, which generally vest within one year from the date of grant, pursuant to the 2010 Plan. To date, the Company has only granted RSU awards to its non-employee directors. RSUs represent an unsecured promise of the Company to issue shares of the Company’s common stock. Unless forfeited prior to the vesting date, RSUs are converted into shares of the Company’s common stock generally on the vesting date. An independent director who receives an RSU award may elect, upon receipt of such award, to defer until a later date delivery of the shares of common stock of the Company that would otherwise be issued to such director on the vesting date. RSUs granted prior to the fiscal year 2012, are generally retained by the Company as deferred stock units that are not distributed until six months after the independent director’s service as a director terminates. RSUs are independent of stock option grants and are generally subject to forfeiture if service terminates prior to the vesting of the units. Participants have no voting rights with respect to unvested RSUs. Under the 2010 Plan, the Company may settle the vested deferred stock units with shares of the Company’s common stock or in cash. | ||||||||||||||
The Company expenses the cost of the RSUs, which is determined to be the fair value of the RSUs at the date of grant, on a straight-line basis over the vesting period (generally one year). For these purposes, the fair value of the RSU is determined based on the closing market price of the Company’s common stock on the date of grant. | ||||||||||||||
The following table presents a summary of the activity for the Company’s RSUs for the three months ended December 31, 2014: | ||||||||||||||
Restricted Stock Units | Number of Shares | Weighted Average | Weighted Average | |||||||||||
(in Thousands) | Fair Value Per | Remaining | ||||||||||||
Share | Vesting Term (in | |||||||||||||
Years) | ||||||||||||||
Unvested at September 30, 2014 | — | $ | — | — | ||||||||||
Granted | 20 | 29.20 | ||||||||||||
Vested | — | — | ||||||||||||
Forfeited | — | — | ||||||||||||
Unvested at December 31, 2014 | 20 | $ | 29.20 | 0.8 | ||||||||||
At December 31, 2014, unrecognized compensation costs related to unvested RSUs are approximately $0.5 million and are expected to be recognized over the weighted average period of 0.8 years. | ||||||||||||||
Commitments_and_Contingencies
Commitments and Contingencies | 3 Months Ended |
Dec. 31, 2014 | |
Commitments and Contingencies | |
Commitments and Contingencies | |
8. Commitments and Contingencies | |
In the fiscal year ended September 30, 2014, the Company disclosed that it had experienced a data security incident. The costs that the Company has incurred to date in connection with the data security incident primarily include professional advisory and legal costs. For the three months ended December 31, 2014, selling, general and administrative expenses reflect a charge of $0.2 million, consisting primarily of these costs relating to the data security incident. | |
The Company may incur additional costs and expenses related to the data security incident in the future. These costs may also result from potential liabilities to payment card networks, governmental or third party investigations, proceedings or litigation and legal and other fees necessary to defend against any potential liabilities or claims. As of December 31, 2014, while the scope of these additional costs, or a range thereof, cannot be reasonably estimated we do not anticipate these additional costs or liabilities would have a material adverse impact on our business, financial condition and operating results. | |
Shortterm_Borrowings_and_LongT
Short-term Borrowings and Long-Term Debt | 3 Months Ended | ||||||
Dec. 31, 2014 | |||||||
Short-term Borrowings and Long-Term Debt | |||||||
Short-term Borrowings and Long-Term Debt | |||||||
9. Short-term Borrowings and Long-term Debt | |||||||
Details of long-term debt as of December 31, 2014 are as follows (dollars in thousands): | |||||||
Amount | Interest Rates | ||||||
ABL facility | $ | — | (i) Prime plus (0.50% to 0.75%) or; | ||||
(ii) LIBOR(a) plus (1.50% to 1.75%) | |||||||
Senior notes due Nov. 2019 | 750,000 | 6.88% | |||||
Senior notes due Jun. 2022(b) | 857,213 | 5.750%(b) | |||||
Senior notes due Nov. 2023 | 200,000 | 5.50% | |||||
Other, due Jun. 2015(c) | 51 | 5.79% | |||||
Total | $ | 1,807,264 | |||||
Capital leases and other | 3,728 | ||||||
Less: current portion | 888 | ||||||
Total long-term debt | $ | 1,810,104 | |||||
(a) | London Interbank Offered Rate (“LIBOR”). | ||||||
(b) | Amounts include unamortized premium of $7.2 million related to notes with an aggregate principal amount of $150.0 million. The 5.75% interest rate relates to notes in the aggregate principal amount of $850.0 million. | ||||||
(c) | Represents pre-acquisition debt of Sinelco Group BVBA (“Sinelco”). | ||||||
In November 2006, the Company, through its subsidiaries (Sally Investment Holdings LLC and Sally Holdings LLC, which we refer to as “Sally Investment” and “Sally Holdings,” respectively) incurred $1,850.0 million of indebtedness in connection with the Company’s separation from its former parent, The Alberto-Culver Company, which we refer to as “Alberto-Culver.” Please see our Annual Report on Form 10-K for the fiscal year ended September 30, 2014 for additional information about the Company’s separation from Alberto-Culver. | |||||||
In the fiscal year ended September 30, 2011, Sally Holdings entered into a $400 million, five-year asset-based senior secured loan facility (the “ABL facility”). The availability of funds under the ABL facility, as amended in June 2012, is subject to a customary borrowing base comprised of: (i) a specified percentage of our eligible credit card and trade accounts receivable (as defined therein) and (ii) a specified percentage of our eligible inventory (as defined therein), and reduced by (iii) certain customary reserves and adjustments and by certain outstanding letters of credit. The ABL facility includes a $25.0 million Canadian sub-facility for our Canadian operations. In July 2013, the Company, Sally Holdings and other parties to the ABL facility entered into a second amendment to the ABL facility which, among other things, increased the maximum availability under the ABL facility to $500.0 million (subject to borrowing base limitations), reduced pricing, relaxed the restrictions regarding the making of Restricted Payments, extended the maturity to July 2018 and improved certain other covenant terms. | |||||||
At December 31, 2014, the Company had $478.1 million available for borrowing under the ABL facility, including the Canadian sub-facility. Borrowings under the ABL facility are secured by the accounts, inventory and credit card receivables of our domestic subsidiaries and Canadian subsidiaries (in the case of borrowings under the Canadian sub-facility), together with general intangibles and certain other personal property of our domestic subsidiaries and Canadian subsidiaries (in the case of borrowings under the Canadian sub-facility) relating to the accounts and inventory, as well as deposit accounts of our domestic subsidiaries and Canadian subsidiaries (in the case of borrowings under the Canadian sub-facility) and, solely with respect to borrowings by SBH Finance B.V., intercompany notes owed to SBH Finance B.V. by our foreign subsidiaries. In addition, the terms of the ABL facility contain a commitment fee of 0.25% on the unused portion of the facility. | |||||||
In the fiscal year ended September 30, 2012, Sally Holdings and Sally Capital Inc. (collectively, the “Issuers”), both indirect wholly-owned subsidiaries of the Company, issued $750.0 million aggregate principal amount of their 6.875% Senior Notes due 2019 (the “senior notes due 2019”) and $850.0 million aggregate principal amount of their 5.75% Senior Notes due 2022 (the “senior notes due 2022”), including notes in the aggregate principal amount of $150.0 million which were issued at par plus a premium. Such premium is being amortized over the term of the notes using the effective interest method. The net proceeds from these debt issuances were used to retire outstanding indebtedness in the aggregate principal amount of approximately $1,391.9 million (substantially all of which was incurred in 2006 in connection with our separation from Alberto-Culver) and for general corporate purposes. | |||||||
On October 29, 2013, the Issuers issued $200.0 million aggregate principal amount of their 5.5% Senior Notes due 2023 (the “senior notes due 2023”). The senior notes due 2023 bear interest at an annual rate of 5.5% and were issued at par. The Company used the net proceeds from this debt issuance, approximately $196.3 million, to repay borrowings outstanding under the ABL facility of $88.5 million (which borrowings were primarily used to fund share repurchases) and for general corporate purposes, including share repurchases. | |||||||
The senior notes due 2019, the senior notes due 2022 and the senior notes due 2023, which we refer to collectively as “the Notes” or “the senior notes due 2019, 2022 and 2023,” are unsecured obligations of the Issuers and are jointly and severally guaranteed by the Company and Sally Investment, and by each material domestic subsidiary of the Company. Interest on the senior notes due 2019, 2022 and 2023 is payable semi-annually, during the Company’s first and third fiscal quarters. Please see Note 12 for certain condensed financial statement data pertaining to Sally Beauty, the Issuers, the guarantor subsidiaries and the non-guarantor subsidiaries. | |||||||
The senior notes due 2019 carry optional redemption features whereby the Company has the option to redeem the notes, in whole or in part, on or after November 15, 2017 at par, plus accrued and unpaid interest, if any, and on or after November 15, 2015 at par plus a premium declining ratably to par, plus accrued and unpaid interest, if any. Prior to November 15, 2015, the notes may be redeemed, in whole or in part, at a redemption price equal to par plus a make-whole premium as provided in the indenture, plus accrued and unpaid interest, if any. | |||||||
The senior notes due 2022 carry optional redemption features whereby the Company has the option to redeem the notes, in whole or in part, on or after June 1, 2020 at par, plus accrued and unpaid interest, if any, and on or after June 1, 2017 at par plus a premium declining ratably to par, plus accrued and unpaid interest, if any. Prior to June 1, 2017, the notes may be redeemed, in whole or in part, at a redemption price equal to par plus a make-whole premium as provided in the indenture, plus accrued and unpaid interest, if any. In addition, on or prior to June 1, 2015, the Company has the right to redeem at par plus a specified premium, plus accrued and unpaid interest, if any, up to 35% of the aggregate principal amount of notes originally issued, subject to certain limitations, with the proceeds from certain kinds of equity offerings, as defined in the indenture. | |||||||
The senior notes due 2023 carry optional redemption features whereby the Company has the option to redeem the notes, in whole or in part, on or after November 1, 2021 at par, plus accrued and unpaid interest, if any, and on or after November 1, 2018 at par plus a premium declining ratably to par, plus accrued and unpaid interest, if any. Prior to November 1, 2018, the notes may be redeemed, in whole or in part, at a redemption price equal to par plus a make-whole premium as provided in the indenture, plus accrued and unpaid interest, if any. In addition, on or prior to November 1, 2016, the Company has the right to redeem at par plus a specified premium, plus accrued and unpaid interest, if any, up to 35% of the aggregate principal amount of notes originally issued, subject to certain limitations, with the proceeds from certain kinds of equity offerings, as defined in the indenture. | |||||||
Maturities of the Company’s long-term debt are as follows as of December 31, 2014 (in thousands): | |||||||
Twelve months ending December 31: | |||||||
2015 | $ | 51 | |||||
2016-2018 | — | ||||||
2019 | 750,000 | ||||||
Thereafter | 1,057,213 | ||||||
$ | 1,807,264 | ||||||
Capital lease obligations | 3,728 | ||||||
Less: current portion | 888 | ||||||
Total | $ | 1,810,104 | |||||
We are a holding company and do not have any material assets or operations other than ownership of equity interests of our subsidiaries. The agreements and instruments governing the debt of Sally Holdings and its subsidiaries contain material limitations on their ability to pay dividends and other restricted payments to us which, in turn, constitute material limitations on our ability to pay dividends and other payments to our stockholders. | |||||||
The ABL facility does not contain any restriction against the incurrence of unsecured indebtedness. However, the ABL facility restricts the incurrence of secured indebtedness if, after giving effect to the incurrence of such secured indebtedness, the Company’s Secured Leverage Ratio exceeds 4.0 to 1.0. At December 31, 2014, the Company’s Secured Leverage Ratio was less than 0.1 to 1.0. Secured Leverage Ratio is defined as the ratio of (i) Secured Funded Indebtedness (as defined in the ABL facility) to (ii) Consolidated EBITDA (as defined in the ABL facility) for the most recently completed twelve fiscal months. | |||||||
The ABL facility is pre-payable and the commitments thereunder may be terminated, in whole or in part, at any time without penalty or premium. | |||||||
The indentures governing the senior notes due 2019, 2022 and 2023 contain terms which restrict the ability of Sally Beauty’s subsidiaries to incur additional indebtedness. However, in addition to certain other material exceptions, the Company may incur additional indebtedness under the indentures if its Consolidated Coverage Ratio, after giving pro forma effect to the incurrence of such indebtedness, exceeds 2.0 to 1.0 (“Incurrence Test”). At December 31, 2014, the Company’s Consolidated Coverage Ratio was approximately 5.5 to 1.0. Consolidated Coverage Ratio is defined as the ratio of (i) Consolidated EBITDA (as defined in the indentures) for the period containing the most recent four consecutive fiscal quarters, to (ii) Consolidated Interest Expense (as defined in the indentures) for such period. | |||||||
The indentures governing the senior notes due 2019, 2022 and 2023 restrict Sally Holdings and its subsidiaries from making certain dividends and distributions to equity holders and certain other restricted payments (hereafter, a “Restricted Payment” or “Restricted Payments”) to us. However, the indentures permit the making of such Restricted Payments if, at the time of the making of such Restricted Payment, the Company satisfies the Incurrence Test as described above and the cumulative amount of all Restricted Payments made since the issue date of the applicable senior notes does not exceed the sum of: (i) 50% of Sally Holdings’ and its subsidiaries’ cumulative consolidated net earnings since July 1, 2006, plus (ii) the proceeds from the issuance of certain equity securities or conversions of indebtedness to equity, in each case, since the issue date of the applicable senior notes plus (iii) the net reduction in investments in unrestricted subsidiaries since the issue date of the applicable senior notes plus (iv) the return of capital with respect to any sales or dispositions of certain minority investments since the issue date of the applicable senior notes. Further, in addition to certain other baskets, the indentures permit the Company to make additional Restricted Payments in an unlimited amount if, after giving pro forma effect to the incurrence of any indebtedness to make such Restricted Payment, the Company’s Consolidated Total Leverage Ratio (as defined in the indentures) is less than 3.25 to 1.00. At December 31, 2014, the Company’s Consolidated Total Leverage Ratio was approximately 2.8 to 1.0. Consolidated Total Leverage Ratio is defined as the ratio of (i) Consolidated Total Indebtedness (as defined in the indentures) minus cash and cash equivalents on-hand up to $100.0 million, in each case, as of the end of the most recently-ended fiscal quarter to (ii) Consolidated EBITDA (as defined in the indentures) for the period containing the most recent four consecutive fiscal quarters. | |||||||
The ABL facility also restricts the making of Restricted Payments. More specifically, under the ABL facility, Sally Holdings may make Restricted Payments if availability under the ABL facility equals or exceeds certain thresholds, and no default then exists under the facility. For Restricted Payments up to $30.0 million during each fiscal year, borrowing availability must equal or exceed the lesser of $75.0 million or 15% of the borrowing base for 45 days prior to such Restricted Payment. For Restricted Payments in excess of that amount, borrowing availability must equal or exceed the lesser of $100.0 million or 20% of the borrowing base for 45 days prior to such Restricted Payment and the Consolidated Fixed Charge Coverage Ratio (as defined below) must equal or exceed 1.1 to 1.0. Further, if borrowing availability equals or exceeds the lesser of $150.0 million or 30% of the borrowing base, Restricted Payments are not limited by the Consolidated Fixed Charge Coverage Ratio test. The Consolidated Fixed Charge Coverage Ratio is defined as the ratio of (i) Consolidated EBITDA (as defined in the ABL facility) during the trailing twelve-month period preceding such proposed Restricted Payment minus certain unfinanced capital expenditures made during such period and income tax payments paid in cash during such period to (ii) fixed charges (as defined in the ABL facility). In addition, during any period that borrowing availability under the ABL facility is less than the greater of $40.0 million or 10% of the borrowing base, the level of the Consolidated Fixed Charge Coverage Ratio that the Company must satisfy is 1.0 to 1.0. As of December 31, 2014, the Consolidated Fixed Charge Coverage Ratio was approximately 3.4 to 1.0. | |||||||
When used in this Quarterly Report, the phrase “Consolidated EBITDA” is intended to have the meaning ascribed to such phrase in the ABL facility or the indentures governing the senior notes due 2019, 2022 and 2023, as appropriate. EBITDA is not a recognized measurement under GAAP and should not be considered a substitute for financial performance and liquidity measures determined in accordance with GAAP, such as net earnings, operating earnings and operating cash flows. | |||||||
The ABL facility and the indentures governing the senior notes due 2019, 2022 and 2023 contain other covenants regarding restrictions on the disposition of assets, the granting of liens and security interests, the prepayment of certain indebtedness, and other matters and customary events of default, including customary cross-default and/or cross-acceleration provisions. As of December 31, 2014, all the net assets of our consolidated subsidiaries were unrestricted from transfer under our credit arrangements. | |||||||
Derivative_Instruments_and_Hed
Derivative Instruments and Hedging Activities | 3 Months Ended | |||||||||||||||||
Dec. 31, 2014 | ||||||||||||||||||
Derivative Instruments and Hedging Activities | ||||||||||||||||||
Derivative Instruments and Hedging Activities | ||||||||||||||||||
10. Derivative Instruments and Hedging Activities | ||||||||||||||||||
Risk Management Objectives of Using Derivative Instruments | ||||||||||||||||||
The Company is exposed to a wide variety of risks, including risks arising from changing economic conditions. The Company manages its exposure to certain economic risks (including liquidity, credit risk, and changes in foreign currency exchange rates and in interest rates) primarily: (a) by closely managing its cash flows from operating and investing activities and the amounts and sources of its debt obligations; (b) by assessing periodically the creditworthiness of its business partners; and (c) through the use of derivative instruments from time to time (including, foreign exchange contracts and interest rate swaps) by Sally Holdings. | ||||||||||||||||||
The Company from time to time uses foreign exchange contracts (including foreign currency forwards and options), as part of its overall economic risk management strategy, to fix the amount of certain foreign assets and obligations relative to its functional and reporting currency (the U.S. dollar) or relative to the functional currency of certain of its consolidated subsidiaries, or to add stability to cash flows resulting from its net investments (including intercompany notes not permanently invested) and earnings denominated in foreign currencies. The Company’s foreign currency exposures at times offset each other, sometimes providing a natural hedge against its foreign currency risk. In connection with the remaining foreign currency risk, the Company uses foreign exchange contracts to effectively fix the foreign currency exchange rate applicable to specific anticipated foreign currency-denominated cash flows, thus limiting the potential fluctuations in such cash flows as a result of foreign currency market movements. | ||||||||||||||||||
The Company from time to time has used interest rate swaps, as part of its overall economic risk management strategy, to add stability to the interest payments due in connection with its debt obligations. At December 31, 2014, our exposure to interest rate fluctuations relates to interest payments under the ABL facility, if any, and the Company held no derivative instruments in connection therewith. | ||||||||||||||||||
As of December 31, 2014, the Company did not purchase or hold any derivative instruments for trading or speculative purposes. | ||||||||||||||||||
Designated Cash Flow Hedges | ||||||||||||||||||
The Company may use from time to time derivative instruments designated as hedges to manage its exposure to interest rate or foreign currency exchange rate movements, as appropriate. The Company did not purchase or hold any such derivatives at December 31, 2014. | ||||||||||||||||||
Non-designated Cash Flow Hedges | ||||||||||||||||||
The Company may use from time to time derivative instruments (such as foreign exchange contracts and interest rate swaps) not designated as hedges or that do not meet the requirements for hedge accounting, to manage its exposure to interest rate or foreign currency exchange rate movements, as appropriate. | ||||||||||||||||||
The Company uses foreign exchange contracts to manage the exposure to the U.S. dollar resulting from certain of its international subsidiaries’ purchases of merchandise from third-party suppliers. These subsidiaries currently have a functional currency other than the U.S. dollar - their functional currency is either the British pound sterling or the Euro. As such, at December 31, 2014, we hold: (a) foreign currency forwards which enable us to sell approximately £4.9 million ($7.6 million, at the December 31, 2014 exchange rate) at the weighted average contractual exchange rate of 1.6268 and (b) foreign currency forwards which enable us to sell approximately €8.8 million ($10.6 million, at the December 31, 2014 exchange rate) at the weighted average contractual exchange rate of 1.2908. These foreign currency forwards expire ratably through September 21, 2015. | ||||||||||||||||||
The Company also uses foreign exchange contracts to mitigate its exposure to changes in foreign currency exchange rates in connection with certain intercompany balances not permanently invested. As such, at December 31, 2014, we hold: (a) a foreign currency forward which enables us to sell approximately €18.1 million ($21.9 million, at the December 31, 2014 exchange rate) at the contractual exchange rate of 1.2183, (b) a foreign currency forward which enables us to sell approximately $5.2 million Canadian dollars ($4.5 million, at the December 31, 2014 exchange rate) at the contractual exchange rate of 1.1621, (c) a foreign currency forward which enables us to buy approximately $15.6 million Canadian dollars ($13.4 million, at the December 31, 2014 exchange rate) at the contractual exchange rate of 1.1664, (d) a foreign currency forward which enables us to sell approximately 30.7 million Mexican pesos ($2.1 million, at the December 31, 2014 exchange rate) at the contractual exchange rate of 14.7790 and (e) a foreign currency forward which enables us to buy approximately £1.1 million ($1.8 million, at the December 31, 2014 exchange rate) at the contractual exchange rate of 1.5511. All the foreign currency forwards discussed in this paragraph expire on or before March 31, 2015. | ||||||||||||||||||
In addition, the Company uses foreign exchange contracts including, at December 31, 2014, foreign currency forwards with an aggregate notional amount of £2.3 million ($3.5 million, at the December 31, 2014 exchange rate) to mitigate the exposure to the British pound sterling resulting from the sale of products and services among certain European subsidiaries of the Company. The foreign currency forwards discussed in this paragraph enable the Company to buy British pound sterling in exchange for Euro currency at the weighted average contractual exchange rate of 0.7984 and expire ratably through September 30, 2015. | ||||||||||||||||||
At December 31, 2014, all of the Company’s foreign exchange contracts are with a single counterparty. The Company’s foreign exchange contracts are not designated as hedges and do not currently meet the requirements for hedge accounting. Accordingly, the changes in the fair value (i.e., marked-to-market adjustments) of these derivative instruments, which are adjusted quarterly, are recorded in selling, general and administrative expenses in our consolidated statements of earnings. During the three months ended December 31, 2014 and 2013, selling, general and administrative expenses include net gains of $1.5 million and net losses of $0.9 million, respectively, in connection with all of the Company’s foreign currency derivative instruments, including marked-to-market adjustments. | ||||||||||||||||||
The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Company’s consolidated balance sheet as of December 31, 2014 and September 30, 2014 (in thousands): | ||||||||||||||||||
Asset Derivatives | Liability Derivatives | |||||||||||||||||
Classification | December 31, | September 30, | Classification | December 31, | September 30, | |||||||||||||
2014 | 2014 | 2014 | 2014 | |||||||||||||||
Derivatives designated as hedging instruments: | ||||||||||||||||||
None | ||||||||||||||||||
Derivatives not designated as hedging instruments: | ||||||||||||||||||
Foreign exchange contracts | Other current assets | $ | 1,284 | $ | 511 | Accrued liabilities | $ | 3 | $ | 47 | ||||||||
$ | 1,284 | $ | 511 | $ | 3 | $ | 47 | |||||||||||
The table below presents the effect of the Company’s derivative financial instruments on the Company’s consolidated statements of earnings for the three months ended December 31, 2014 and 2013 (in thousands): | ||||||||||||||||||
Derivatives | Amount of Gain or (Loss) Recognized in OCI | Amount of Gain or (Loss) Reclassified from | ||||||||||||||||
Designated as | on Derivative (Effective Portion), net of tax | Accumulated OCI into Income (Effective Portion) | ||||||||||||||||
Hedging Instruments | ||||||||||||||||||
None | ||||||||||||||||||
Classification of Gain or | Amount of Gain or (Loss) Recognized in Income on | |||||||||||||||||
Derivatives | ||||||||||||||||||
Derivatives Not Designated as | (Loss) Recognized into | Three Months Ended December 31, | ||||||||||||||||
Hedging Instruments | Income | 2014 | 2013 | |||||||||||||||
Foreign exchange contracts | Selling, general and administrative expenses | $ | 1,504 | $ | (858 | ) | ||||||||||||
Credit-risk-related Contingent Features | ||||||||||||||||||
At December 31, 2014, the aggregate fair value of all foreign exchange contracts held which consisted of derivative instruments in a liability position was less than $0.1 million. The Company was under no obligation to post and had not posted any collateral related to the agreements in a liability position. | ||||||||||||||||||
The counterparty to our derivative instruments is deemed by the Company to be of substantial resources and strong creditworthiness. However, these transactions result in exposure to credit risk in the event of default by the counterparty. The financial crisis that has affected the banking systems and financial markets in recent years resulted in many well-known financial institutions becoming less creditworthy or having diminished liquidity which could expose us to an increased level of counterparty credit risk. In the event that the counterparty defaults in its obligation under our derivative instruments, we could incur substantial financial losses. However, at the present time, no such losses are deemed probable. | ||||||||||||||||||
Business_Segments
Business Segments | 3 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Business Segments | ||||||||
Business Segments | ||||||||
11. Business Segments | ||||||||
The Company’s business is organized into two separate segments: (i) Sally Beauty Supply, a domestic and international chain of cash and carry retail stores which offers professional beauty supplies to both salon professionals and retail customers primarily in North America, Puerto Rico, and parts of Europe and South America and (ii) BSG, including its franchise-based business Armstrong McCall, a full service beauty supply distributor which offers professional brands of beauty products directly to salons and salon professionals through its own sales force and professional-only stores (including franchise stores) in partially exclusive geographical territories in North America, Puerto Rico and parts of Europe. | ||||||||
The accounting policies of both of our business segments are the same as described in the summary of significant accounting policies contained in Note 2 of the “Notes to Consolidated Financial Statements” in “Item 8 - Financial Statements and Supplementary Data” contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2014. Sales between segments, which were eliminated in consolidation, were not material during the three months ended December 31, 2014 and 2013. | ||||||||
Segment data for the three months ended December 31, 2014 and 2013 is as follows (in thousands): | ||||||||
Three Months Ended | ||||||||
December 31, | ||||||||
2014 | 2013 | |||||||
Net sales: | ||||||||
Sally Beauty Supply | $ | 586,519 | $ | 573,355 | ||||
BSG | 377,949 | 367,109 | ||||||
Total | $ | 964,468 | $ | 940,464 | ||||
Earnings before provision for income taxes: | ||||||||
Segment operating profit: | ||||||||
Sally Beauty Supply | $ | 101,179 | $ | 103,543 | ||||
BSG | 56,589 | 54,834 | ||||||
Segment operating profit | 157,768 | 158,377 | ||||||
Unallocated expenses (a) | (33,772 | ) | (28,062 | ) | ||||
Share-based compensation expense | (7,760 | ) | (8,522 | ) | ||||
Interest expense | (29,241 | ) | (28,489 | ) | ||||
Earnings before provision for income taxes | $ | 86,995 | $ | 93,304 | ||||
(a) | Unallocated expenses consist of corporate and shared costs. | |||||||
Parent_Issuers_Guarantor_and_N
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements | 3 Months Ended | |||||||||||||||||||
Dec. 31, 2014 | ||||||||||||||||||||
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements | ||||||||||||||||||||
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements | ||||||||||||||||||||
12. Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements | ||||||||||||||||||||
The following consolidating financial information presents the condensed consolidating balance sheets as of December 31, 2014 and September 30, 2014, and the related condensed consolidating statements of earnings, condensed consolidating statements of comprehensive income and condensed consolidating statements of cash flows for the three months ended December 31, 2014 and 2013: (i) Sally Beauty Holdings, Inc., or the “Parent;” (ii) Sally Holdings LLC and Sally Capital Inc., or the “Issuers;” (iii) the guarantor subsidiaries; (iv) the non-guarantor subsidiaries; (v) elimination entries necessary for consolidation purposes; and (vi) Sally Beauty on a consolidated basis. | ||||||||||||||||||||
Investments in subsidiaries are accounted for using the equity method for purposes of the consolidating presentation. The principal elimination entries relate to investments in subsidiaries and intercompany balances and transactions. Separate financial statements and other disclosures with respect to the guarantor subsidiaries have not been provided as management believes the following information is sufficient, as guarantor subsidiaries are 100% indirectly owned by the Parent and all guarantees are full and unconditional. Additionally, the accounts, inventory, credit card receivables, deposit accounts, certain intercompany notes and certain other personal property of the guarantor subsidiaries relating to the inventory and accounts are pledged under the ABL facility and consequently may not be available to satisfy the claims of general creditors. | ||||||||||||||||||||
Condensed Consolidating Balance Sheet | ||||||||||||||||||||
December 31, 2014 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
Holdings | Subsidiaries | Guarantor | Eliminations | Holdings, | ||||||||||||||||
LLC and | Subsidiaries | Inc. and | ||||||||||||||||||
Sally Capital | Subsidiaries | |||||||||||||||||||
Inc. | ||||||||||||||||||||
Assets | ||||||||||||||||||||
Cash and cash equivalents | $ | — | $ | 107,501 | $ | 40,440 | $ | 42,740 | $ | — | $ | 190,681 | ||||||||
Trade and other accounts receivable, less allowance for doubtful accounts | — | — | 58,231 | 29,420 | — | 87,651 | ||||||||||||||
Due from affiliates | — | — | 1,540,318 | 447 | (1,540,765 | ) | — | |||||||||||||
Inventory | — | — | 641,006 | 196,816 | — | 837,822 | ||||||||||||||
Other current assets | 5,448 | 1,251 | 13,115 | 16,054 | — | 35,868 | ||||||||||||||
Deferred income tax assets, net | (213 | ) | 1 | 30,527 | 1,431 | — | 31,746 | |||||||||||||
Property and equipment, net | 1 | — | 158,962 | 77,715 | — | 236,678 | ||||||||||||||
Investment in subsidiaries | 510,580 | 2,892,899 | 380,787 | — | (3,784,266 | ) | — | |||||||||||||
Goodwill and other intangible assets, net | — | — | 472,901 | 168,100 | — | 641,001 | ||||||||||||||
Other assets | — | 27,751 | 1,610 | 6,226 | — | 35,587 | ||||||||||||||
Total assets | $ | 515,816 | $ | 3,029,403 | $ | 3,337,897 | $ | 538,949 | $ | (5,325,031 | ) | $ | 2,097,034 | |||||||
Liabilities and Stockholders’ (Deficit) Equity | ||||||||||||||||||||
Accounts payable | $ | 6 | $ | — | $ | 207,454 | $ | 57,313 | $ | — | $ | 264,773 | ||||||||
Due to affiliates | 772,232 | 697,914 | 447 | 70,172 | (1,540,765 | ) | — | |||||||||||||
Accrued liabilities | 559 | 12,876 | 122,182 | 25,013 | — | 160,630 | ||||||||||||||
Income taxes payable | — | 1,120 | 1 | 2,603 | — | 3,724 | ||||||||||||||
Long-term debt | — | 1,807,213 | 223 | 3,556 | — | 1,810,992 | ||||||||||||||
Other liabilities | — | — | 26,069 | 2,834 | — | 28,903 | ||||||||||||||
Deferred income tax liabilities, net | (1,425 | ) | (300 | ) | 88,622 | (3,329 | ) | — | 83,568 | |||||||||||
Total liabilities | 771,372 | 2,518,823 | 444,998 | 158,162 | (1,540,765 | ) | 2,352,590 | |||||||||||||
Total stockholders’ (deficit) equity | (255,556 | ) | 510,580 | 2,892,899 | 380,787 | (3,784,266 | ) | (255,556 | ) | |||||||||||
Total liabilities and stockholders’ (deficit) equity | $ | 515,816 | $ | 3,029,403 | $ | 3,337,897 | $ | 538,949 | $ | (5,325,031 | ) | $ | 2,097,034 | |||||||
Condensed Consolidating Balance Sheet | ||||||||||||||||||||
September 30, 2014 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
Holdings | Subsidiaries | Guarantor | Eliminations | Holdings, | ||||||||||||||||
LLC and | Subsidiaries | Inc. and | ||||||||||||||||||
Sally Capital | Subsidiaries | |||||||||||||||||||
Inc. | ||||||||||||||||||||
Assets | ||||||||||||||||||||
Cash and cash equivalents | $ | — | $ | 27,000 | $ | 40,042 | $ | 39,533 | $ | — | $ | 106,575 | ||||||||
Trade and other accounts receivable, less allowance for doubtful accounts | 2 | — | 63,009 | 35,489 | — | 98,500 | ||||||||||||||
Due from affiliates | — | — | 1,464,752 | 27 | (1,464,779 | ) | — | |||||||||||||
Inventory | — | — | 631,786 | 196,643 | — | 828,429 | ||||||||||||||
Other current assets | 7,935 | 452 | 15,016 | 15,592 | — | 38,995 | ||||||||||||||
Deferred income tax assets, net | (213 | ) | 1 | 30,527 | 1,335 | — | 31,650 | |||||||||||||
Property and equipment, net | 1 | — | 158,402 | 79,708 | — | 238,111 | ||||||||||||||
Investment in subsidiaries | 471,320 | 2,835,722 | 392,270 | — | (3,699,312 | ) | — | |||||||||||||
Goodwill and other intangible assets, net | — | — | 476,113 | 174,972 | — | 651,085 | ||||||||||||||
Other assets | — | 28,931 | 1,625 | 6,072 | — | 36,628 | ||||||||||||||
Total assets | $ | 479,045 | $ | 2,892,106 | $ | 3,273,542 | $ | 549,371 | $ | (5,164,091 | ) | $ | 2,029,973 | |||||||
Liabilities and Stockholders’ (Deficit) Equity | ||||||||||||||||||||
Accounts payable | $ | — | $ | — | $ | 202,743 | $ | 56,720 | $ | — | $ | 259,463 | ||||||||
Due to affiliates | 826,819 | 571,847 | 27 | 66,086 | (1,464,779 | ) | — | |||||||||||||
Accrued liabilities | 691 | 40,751 | 129,791 | 27,536 | — | 198,769 | ||||||||||||||
Income taxes payable | — | 1,051 | 1 | 3,279 | — | 4,331 | ||||||||||||||
Long-term debt | — | 1,807,447 | 267 | 3,927 | — | 1,811,641 | ||||||||||||||
Other liabilities | — | — | 25,020 | 2,828 | — | 27,848 | ||||||||||||||
Deferred income tax liabilities, net | (1,412 | ) | (310 | ) | 79,971 | (3,275 | ) | — | 74,974 | |||||||||||
Total liabilities | 826,098 | 2,420,786 | 437,820 | 157,101 | (1,464,779 | ) | 2,377,026 | |||||||||||||
Total stockholders’ (deficit) equity | (347,053 | ) | 471,320 | 2,835,722 | 392,270 | (3,699,312 | ) | (347,053 | ) | |||||||||||
Total liabilities and stockholders’ (deficit) equity | $ | 479,045 | $ | 2,892,106 | $ | 3,273,542 | $ | 549,371 | $ | (5,164,091 | ) | $ | 2,029,973 | |||||||
Condensed Consolidating Statement of Earnings and Comprehensive Income | ||||||||||||||||||||
Three Months Ended December 31, 2014 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally Holdings | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
LLC and Sally | Subsidiaries | Guarantor | Eliminations | Holdings, Inc. | ||||||||||||||||
Capital Inc. | Subsidiaries | and Subsidiaries | ||||||||||||||||||
Net sales | $ | — | $ | — | $ | 767,923 | $ | 196,545 | $ | — | $ | 964,468 | ||||||||
Related party sales | — | — | 767 | — | (767 | ) | — | |||||||||||||
Cost of products sold and distribution expenses | — | — | 386,816 | 104,650 | (767 | ) | 490,699 | |||||||||||||
Gross profit | — | — | 381,874 | 91,895 | — | 473,769 | ||||||||||||||
Selling, general and administrative expenses | 2,376 | 104 | 257,786 | 76,688 | — | 336,954 | ||||||||||||||
Depreciation and amortization | — | — | 14,854 | 5,725 | — | 20,579 | ||||||||||||||
Operating earnings (loss) | (2,376 | ) | (104 | ) | 109,234 | 9,482 | — | 116,236 | ||||||||||||
Interest expense | — | 29,193 | 2 | 46 | — | 29,241 | ||||||||||||||
Earnings (loss) before provision for income taxes | (2,376 | ) | (29,297 | ) | 109,232 | 9,436 | — | 86,995 | ||||||||||||
Provision (benefit) for income taxes | (724 | ) | (11,379 | ) | 40,872 | 3,317 | — | 32,086 | ||||||||||||
Equity in earnings of subsidiaries, net of tax | 56,561 | 74,479 | 6,119 | — | (137,159 | ) | — | |||||||||||||
Net earnings | 54,909 | 56,561 | 74,479 | 6,119 | (137,159 | ) | 54,909 | |||||||||||||
Other comprehensive income (loss), net of tax | — | — | — | (17,301 | ) | — | (17,301 | ) | ||||||||||||
Total comprehensive income (loss) | $ | 54,909 | $ | 56,561 | $ | 74,479 | $ | (11,182 | ) | $ | (137,159 | ) | $ | 37,608 | ||||||
Condensed Consolidating Statement of Earnings and Comprehensive Income | ||||||||||||||||||||
Three Months Ended December 31, 2013 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally Holdings | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
LLC and Sally | Subsidiaries | Guarantor | Eliminations | Holdings, Inc. | ||||||||||||||||
Capital Inc. | Subsidiaries | and Subsidiaries | ||||||||||||||||||
Net sales | $ | — | $ | — | $ | 743,276 | $ | 197,188 | $ | — | $ | 940,464 | ||||||||
Related party sales | — | — | 803 | — | (803 | ) | — | |||||||||||||
Cost of products sold and distribution expenses | — | — | 374,681 | 106,060 | (803 | ) | 479,938 | |||||||||||||
Gross profit | — | — | 369,398 | 91,128 | — | 460,526 | ||||||||||||||
Selling, general and administrative expenses | 2,463 | 112 | 241,881 | 75,022 | — | 319,478 | ||||||||||||||
Depreciation and amortization | — | — | 13,870 | 5,385 | — | 19,255 | ||||||||||||||
Operating earnings (loss) | (2,463 | ) | (112 | ) | 113,647 | 10,721 | — | 121,793 | ||||||||||||
Interest expense | — | 28,425 | 1 | 63 | — | 28,489 | ||||||||||||||
Earnings (loss) before provision for income taxes | (2,463 | ) | (28,537 | ) | 113,646 | 10,658 | — | 93,304 | ||||||||||||
Provision (benefit) for income taxes | (932 | ) | (11,080 | ) | 43,980 | 3,341 | — | 35,309 | ||||||||||||
Equity in earnings of subsidiaries, net of tax | 59,526 | 76,983 | 7,317 | — | (143,826 | ) | — | |||||||||||||
Net earnings | 57,995 | 59,526 | 76,983 | 7,317 | (143,826 | ) | 57,995 | |||||||||||||
Other comprehensive income, net of tax | — | — | — | 2,567 | — | 2,567 | ||||||||||||||
Total comprehensive income | $ | 57,995 | $ | 59,526 | $ | 76,983 | $ | 9,884 | $ | (143,826 | ) | $ | 60,562 | |||||||
Condensed Consolidating Statement of Cash Flows | ||||||||||||||||||||
Three months ended December 31, 2014 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally Holdings | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
LLC and | Subsidiaries | Guarantor | Eliminations | Holdings, | ||||||||||||||||
Sally Capital | Subsidiaries | Inc. and | ||||||||||||||||||
Inc. | Subsidiaries | |||||||||||||||||||
Net cash (used) provided by operating activities | $ | (46,946 | ) | $ | 80,501 | $ | 12,356 | $ | 11,125 | $ | — | $ | 57,036 | |||||||
Cash Flows from Investing Activities: | ||||||||||||||||||||
Capital expenditures, net of proceeds from sale of property and equipment | — | — | (11,915 | ) | (6,885 | ) | — | (18,800 | ) | |||||||||||
Net cash used by investing activities | — | — | (11,915 | ) | (6,885 | ) | — | (18,800 | ) | |||||||||||
Cash Flows from Financing Activities: | ||||||||||||||||||||
Repayments of long-term debt | — | — | (43 | ) | (215 | ) | — | (258 | ) | |||||||||||
Repurchases of common stock | (7,253 | ) | — | — | — | — | (7,253 | ) | ||||||||||||
Proceeds from exercises of stock options | 37,156 | — | — | — | — | 37,156 | ||||||||||||||
Excess tax benefit from share-based compensation | 17,043 | — | — | — | — | 17,043 | ||||||||||||||
Net cash provided (used) by financing activities | 46,946 | — | (43 | ) | (215 | ) | — | 46,688 | ||||||||||||
Effect of foreign exchange rate changes on cash and cash equivalents | — | — | — | (818 | ) | — | (818 | ) | ||||||||||||
Net increase in cash and cash equivalents | — | 80,501 | 398 | 3,207 | — | 84,106 | ||||||||||||||
Cash and cash equivalents, beginning of period | — | 27,000 | 40,042 | 39,533 | — | 106,575 | ||||||||||||||
Cash and cash equivalents, end of period | $ | — | $ | 107,501 | $ | 40,440 | $ | 42,740 | $ | — | $ | 190,681 | ||||||||
Condensed Consolidating Statement of Cash Flows | ||||||||||||||||||||
Three Months Ended December 31, 2013 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally Holdings | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
LLC and | Subsidiaries | Guarantor | Eliminations | Holdings, | ||||||||||||||||
Sally Capital | Subsidiaries | Inc. and | ||||||||||||||||||
Inc. | Subsidiaries | |||||||||||||||||||
Net cash provided (used) by operating activities | $ | 55,879 | $ | (41,111 | ) | $ | 34,374 | $ | 10,962 | $ | — | $ | 60,104 | |||||||
Cash Flows from Investing Activities: | ||||||||||||||||||||
Capital expenditures, net of proceeds from sale of property and equipment | — | — | (7,766 | ) | (5,609 | ) | — | (13,375 | ) | |||||||||||
Net cash used by investing activities | — | — | (7,766 | ) | (5,609 | ) | — | (13,375 | ) | |||||||||||
Cash Flows from Financing Activities: | ||||||||||||||||||||
Proceeds from issuance of long-term debt | — | 232,500 | 219 | — | — | 232,719 | ||||||||||||||
Repayments of long-term debt | — | (108,500 | ) | (39 | ) | (486 | ) | — | (109,025 | ) | ||||||||||
Debt issuance costs | — | (3,888 | ) | — | — | — | (3,888 | ) | ||||||||||||
Repurchases of common stock | (66,183 | ) | — | — | — | — | (66,183 | ) | ||||||||||||
Proceeds from exercises of stock options | 7,319 | — | — | — | — | 7,319 | ||||||||||||||
Excess tax benefit from share-based compensation | 2,985 | — | — | — | — | 2,985 | ||||||||||||||
Net cash (used) provided by financing activities | (55,879 | ) | 120,112 | 180 | (486 | ) | — | 63,927 | ||||||||||||
Effect of foreign exchange rate changes on cash and cash equivalents | — | — | — | 153 | — | 153 | ||||||||||||||
Net increase in cash and cash equivalents | — | 79,001 | 26,788 | 5,020 | — | 110,809 | ||||||||||||||
Cash and cash equivalents, beginning of period | — | — | 16,337 | 30,778 | — | 47,115 | ||||||||||||||
Cash and cash equivalents, end of period | $ | — | $ | 79,001 | $ | 43,125 | $ | 35,798 | $ | — | $ | 157,924 | ||||||||
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 3 Months Ended | ||||||||||||
Dec. 31, 2014 | |||||||||||||
Fair Value Measurements | |||||||||||||
Schedule of financial assets and liabilities by fair value hierarchy | |||||||||||||
Consistent with this hierarchy, the Company categorized certain of its financial assets and liabilities as follows at December 31, 2014 and September 30, 2014 (in thousands): | |||||||||||||
As of December 31, 2014 | |||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||
Assets | |||||||||||||
Cash equivalents (a) | $ | 107,501 | $ | 107,501 | $ | — | — | ||||||
Foreign exchange contracts (b) | 1,284 | — | 1,284 | — | |||||||||
Total assets | $ | 108,785 | $ | 107,501 | $ | 1,284 | — | ||||||
Liabilities | |||||||||||||
Long-term debt (c) | $ | 1,893,779 | $ | 1,890,000 | $ | 3,779 | — | ||||||
Foreign exchange contracts (b) | 3 | — | 3 | — | |||||||||
Total liabilities | $ | 1,893,782 | $ | 1,890,000 | $ | 3,782 | — | ||||||
As of September 30, 2014 | |||||||||||||
Total | Level 1 | Level 2 | Level 3 | ||||||||||
Assets | |||||||||||||
Cash equivalents (a) | $ | 27,000 | $ | 27,000 | $ | — | — | ||||||
Foreign exchange contracts (b) | 511 | — | 511 | — | |||||||||
Total assets | $ | 27,511 | $ | 27,000 | $ | 511 | — | ||||||
Liabilities | |||||||||||||
Long-term debt (c) | $ | 1,874,444 | $ | 1,870,250 | $ | 4,194 | — | ||||||
Foreign exchange contracts (b) | 47 | — | 47 | — | |||||||||
Total liabilities | $ | 1,874,491 | $ | 1,870,250 | $ | 4,241 | — | ||||||
(a) | Cash equivalents consist of highly liquid investments which have no maturity and are valued using unadjusted quoted market prices for such securities. The Company may from time to time invest in securities with maturities of three months or less (consisting primarily of investment-grade corporate and government bonds), with the primary investment objective of minimizing the potential risk of loss of principal. | ||||||||||||
(b) | Foreign exchange contracts (including foreign currency forwards and options) are valued for purposes of this disclosure using widely accepted valuation techniques, such as discounted cash flow analyses, and reasonable estimates, such as market foreign currency exchange rates. Please see Note 10 for more information about the Company’s foreign exchange contracts. | ||||||||||||
(c) | Long-term debt (including current maturities and borrowings under the ABL facility, if any) is carried in the Company’s consolidated financial statements at amortized cost of $1,811.0 million at December 31, 2014 and $1,811.6 million at September 30, 2014. The Company’s senior notes are valued for purposes of this disclosure using unadjusted quoted market prices for such debt securities. Other long-term debt (consisting primarily of borrowings under the ABL facility, if any, and capital lease obligations) is generally valued for purposes of this disclosure using widely accepted valuation techniques, such as discounted cash flow analyses, and observable inputs, such as market interest rates. Please see Note 9 for more information about the Company’s debt. | ||||||||||||
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 3 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Earnings Per Share | ||||||||
Schedule of computations of basic and diluted earnings per share | ||||||||
The following table sets forth the computations of basic and diluted earnings per share (in thousands, except per share data): | ||||||||
Three Months Ended | ||||||||
December 31, | ||||||||
2014 | 2013 | |||||||
Net earnings | $ | 54,909 | $ | 57,995 | ||||
Weighted average basic shares | 156,104 | 163,603 | ||||||
Dilutive securities: | ||||||||
Stock option and stock award programs | 2,441 | 4,152 | ||||||
Weighted average diluted shares | 158,545 | 167,755 | ||||||
Earnings per share: | ||||||||
Basic | $ | 0.35 | $ | 0.35 | ||||
Diluted | $ | 0.35 | $ | 0.35 | ||||
ShareBased_Payments_Tables
Share-Based Payments (Tables) | 3 Months Ended | |||||||||||||
Dec. 31, 2014 | ||||||||||||||
Share-Based Payments | ||||||||||||||
Schedule of total compensation cost charged against income | ||||||||||||||
The following table presents the total compensation cost charged against income and included in selling, general and administrative expenses for all share-based compensation arrangements and the related tax benefits recognized in our consolidated statements of earnings (in thousands): | ||||||||||||||
Three Months Ended | ||||||||||||||
December 31, | ||||||||||||||
2014 | 2013 | |||||||||||||
Share-based compensation expense | $ | 7,760 | $ | 8,522 | ||||||||||
Income tax benefit related to share-based compensation expense | $ | 2,918 | $ | 3,181 | ||||||||||
Summary of activity for stock option awards | ||||||||||||||
Number of | Weighted | Weighted | Aggregate | |||||||||||
Outstanding | Average | Average | Intrinsic | |||||||||||
Options (in | Exercise | Remaining | Value (in | |||||||||||
Thousands) | Price | Contractual | Thousands) | |||||||||||
Term (in | ||||||||||||||
Years) | ||||||||||||||
Outstanding at September 30, 2014 | 8,983 | $ | 15.93 | 6.2 | $ | 102,751 | ||||||||
Granted | 1,132 | 29.2 | ||||||||||||
Exercised | (3,265 | ) | 11.38 | |||||||||||
Forfeited or expired | (33 | ) | 22.64 | |||||||||||
Outstanding at December 31, 2014 | 6,817 | $ | 20.28 | 7.1 | $ | 71,282 | ||||||||
Exercisable at December 31, 2014 | 3,405 | $ | 14.78 | 5.5 | $ | 54,366 | ||||||||
Summary of stock options by range of exercise prices | ||||||||||||||
Options Outstanding | Options Exercisable | |||||||||||||
Range of | Number | Weighted | Weighted | Number | Weighted | |||||||||
Exercise Prices | Outstanding at | Average | Average | Exercisable at | Average | |||||||||
December 31, | Remaining | Exercise | December 31, | Exercise | ||||||||||
2014 (in | Contractual | Price | 2014 (in | Price | ||||||||||
Thousands) | Term (in | Thousands) | ||||||||||||
Years) | ||||||||||||||
$2.00 — 19.99 | 3,026 | 5.0 | $ | 12.79 | 2,617 | $ | 11.78 | |||||||
$20.00 — 29.20 | 3,791 | 8.7 | 26.27 | 788 | 24.70 | |||||||||
Total | 6,817 | 7.1 | $ | 20.28 | 3,405 | $ | 14.78 | |||||||
Schedule of weighted average assumptions for valuation of stock options | ||||||||||||||
Three months ended | ||||||||||||||
December 31, | ||||||||||||||
2014 | 2013 | |||||||||||||
Expected life (in years) | 5.0 | 5.0 | ||||||||||||
Expected volatility for the Company’s stock | 31.0 | % | 48.4 | % | ||||||||||
Risk-free interest rate | 1.6 | % | 1.3 | % | ||||||||||
Dividend yield | 0.0 | % | 0.0 | % | ||||||||||
Restricted Stock Awards | ||||||||||||||
Share-Based Payments | ||||||||||||||
Summary of the activity for restricted stock awards/units | ||||||||||||||
Restricted Stock Awards | Number of Shares | Weighted Average | Weighted Average | |||||||||||
(in Thousands) | Fair Value Per | Remaining | ||||||||||||
Share | Vesting Term (in | |||||||||||||
Years) | ||||||||||||||
Unvested at September 30, 2014 | 436 | $ | 22.42 | 3.4 | ||||||||||
Granted | 214 | 29.2 | ||||||||||||
Vested | (83 | ) | 14.3 | |||||||||||
Forfeited | — | — | ||||||||||||
Unvested at December 31, 2014 | 567 | $ | 26.16 | 3.2 | ||||||||||
Restricted Stock Units | ||||||||||||||
Share-Based Payments | ||||||||||||||
Summary of the activity for restricted stock awards/units | ||||||||||||||
Restricted Stock Units | Number of Shares | Weighted Average | Weighted Average | |||||||||||
(in Thousands) | Fair Value Per | Remaining | ||||||||||||
Share | Vesting Term (in | |||||||||||||
Years) | ||||||||||||||
Unvested at September 30, 2014 | — | $ | — | — | ||||||||||
Granted | 20 | 29.20 | ||||||||||||
Vested | — | — | ||||||||||||
Forfeited | — | — | ||||||||||||
Unvested at December 31, 2014 | 20 | $ | 29.20 | 0.8 | ||||||||||
Shortterm_Borrowings_and_LongT1
Short-term Borrowings and Long-Term Debt (Tables) | 3 Months Ended | ||||||
Dec. 31, 2014 | |||||||
Short-term Borrowings and Long-Term Debt | |||||||
Summary of long-term debt | |||||||
Details of long-term debt as of December 31, 2014 are as follows (dollars in thousands): | |||||||
Amount | Interest Rates | ||||||
ABL facility | $ | — | (i) Prime plus (0.50% to 0.75%) or; | ||||
(ii) LIBOR(a) plus (1.50% to 1.75%) | |||||||
Senior notes due Nov. 2019 | 750,000 | 6.88% | |||||
Senior notes due Jun. 2022(b) | 857,213 | 5.750%(b) | |||||
Senior notes due Nov. 2023 | 200,000 | 5.50% | |||||
Other, due Jun. 2015(c) | 51 | 5.79% | |||||
Total | $ | 1,807,264 | |||||
Capital leases and other | 3,728 | ||||||
Less: current portion | 888 | ||||||
Total long-term debt | $ | 1,810,104 | |||||
(a) | London Interbank Offered Rate (“LIBOR”). | ||||||
(b) | Amounts include unamortized premium of $7.2 million related to notes with an aggregate principal amount of $150.0 million. The 5.75% interest rate relates to notes in the aggregate principal amount of $850.0 million. | ||||||
(c) | Represents pre-acquisition debt of Sinelco Group BVBA (“Sinelco”). | ||||||
Schedule of maturities of long-term debt | |||||||
Maturities of the Company’s long-term debt are as follows as of December 31, 2014 (in thousands): | |||||||
Twelve months ending December 31: | |||||||
2015 | $ | 51 | |||||
2016-2018 | — | ||||||
2019 | 750,000 | ||||||
Thereafter | 1,057,213 | ||||||
$ | 1,807,264 | ||||||
Capital lease obligations | 3,728 | ||||||
Less: current portion | 888 | ||||||
Total | $ | 1,810,104 | |||||
Derivative_Instruments_and_Hed1
Derivative Instruments and Hedging Activities (Tables) | 3 Months Ended | |||||||||||||||||
Dec. 31, 2014 | ||||||||||||||||||
Derivative Instruments and Hedging Activities | ||||||||||||||||||
Tabular disclosure of fair values of derivative instruments | ||||||||||||||||||
The table below presents the fair value of the Company’s derivative financial instruments as well as their classification on the Company’s consolidated balance sheet as of December 31, 2014 and September 30, 2014 (in thousands): | ||||||||||||||||||
Asset Derivatives | Liability Derivatives | |||||||||||||||||
Classification | December 31, | September 30, | Classification | December 31, | September 30, | |||||||||||||
2014 | 2014 | 2014 | 2014 | |||||||||||||||
Derivatives designated as hedging instruments: | ||||||||||||||||||
None | ||||||||||||||||||
Derivatives not designated as hedging instruments: | ||||||||||||||||||
Foreign exchange contracts | Other current assets | $ | 1,284 | $ | 511 | Accrued liabilities | $ | 3 | $ | 47 | ||||||||
$ | 1,284 | $ | 511 | $ | 3 | $ | 47 | |||||||||||
Tabular disclosure of the effect of derivative instruments on the statement of earnings | ||||||||||||||||||
The table below presents the effect of the Company’s derivative financial instruments on the Company’s consolidated statements of earnings for the three months ended December 31, 2014 and 2013 (in thousands): | ||||||||||||||||||
Derivatives | Amount of Gain or (Loss) Recognized in OCI | Amount of Gain or (Loss) Reclassified from | ||||||||||||||||
Designated as | on Derivative (Effective Portion), net of tax | Accumulated OCI into Income (Effective Portion) | ||||||||||||||||
Hedging Instruments | ||||||||||||||||||
None | ||||||||||||||||||
Classification of Gain or | Amount of Gain or (Loss) Recognized in Income on | |||||||||||||||||
Derivatives | ||||||||||||||||||
Derivatives Not Designated as | (Loss) Recognized into | Three Months Ended December 31, | ||||||||||||||||
Hedging Instruments | Income | 2014 | 2013 | |||||||||||||||
Foreign exchange contracts | Selling, general and administrative expenses | $ | 1,504 | $ | (858 | ) | ||||||||||||
Business_Segments_Tables
Business Segments (Tables) | 3 Months Ended | |||||||
Dec. 31, 2014 | ||||||||
Business Segments | ||||||||
Schedule of segment data | ||||||||
Segment data for the three months ended December 31, 2014 and 2013 is as follows (in thousands): | ||||||||
Three Months Ended | ||||||||
December 31, | ||||||||
2014 | 2013 | |||||||
Net sales: | ||||||||
Sally Beauty Supply | $ | 586,519 | $ | 573,355 | ||||
BSG | 377,949 | 367,109 | ||||||
Total | $ | 964,468 | $ | 940,464 | ||||
Earnings before provision for income taxes: | ||||||||
Segment operating profit: | ||||||||
Sally Beauty Supply | $ | 101,179 | $ | 103,543 | ||||
BSG | 56,589 | 54,834 | ||||||
Segment operating profit | 157,768 | 158,377 | ||||||
Unallocated expenses (a) | (33,772 | ) | (28,062 | ) | ||||
Share-based compensation expense | (7,760 | ) | (8,522 | ) | ||||
Interest expense | (29,241 | ) | (28,489 | ) | ||||
Earnings before provision for income taxes | $ | 86,995 | $ | 93,304 | ||||
(a) | Unallocated expenses consist of corporate and shared costs. | |||||||
Parent_Issuers_Guarantor_and_N1
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements (Tables) | 3 Months Ended | |||||||||||||||||||
Dec. 31, 2014 | ||||||||||||||||||||
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements | ||||||||||||||||||||
Schedule of Condensed Consolidating Balance Sheet | ||||||||||||||||||||
Condensed Consolidating Balance Sheet | ||||||||||||||||||||
December 31, 2014 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
Holdings | Subsidiaries | Guarantor | Eliminations | Holdings, | ||||||||||||||||
LLC and | Subsidiaries | Inc. and | ||||||||||||||||||
Sally Capital | Subsidiaries | |||||||||||||||||||
Inc. | ||||||||||||||||||||
Assets | ||||||||||||||||||||
Cash and cash equivalents | $ | — | $ | 107,501 | $ | 40,440 | $ | 42,740 | $ | — | $ | 190,681 | ||||||||
Trade and other accounts receivable, less allowance for doubtful accounts | — | — | 58,231 | 29,420 | — | 87,651 | ||||||||||||||
Due from affiliates | — | — | 1,540,318 | 447 | (1,540,765 | ) | — | |||||||||||||
Inventory | — | — | 641,006 | 196,816 | — | 837,822 | ||||||||||||||
Other current assets | 5,448 | 1,251 | 13,115 | 16,054 | — | 35,868 | ||||||||||||||
Deferred income tax assets, net | (213 | ) | 1 | 30,527 | 1,431 | — | 31,746 | |||||||||||||
Property and equipment, net | 1 | — | 158,962 | 77,715 | — | 236,678 | ||||||||||||||
Investment in subsidiaries | 510,580 | 2,892,899 | 380,787 | — | (3,784,266 | ) | — | |||||||||||||
Goodwill and other intangible assets, net | — | — | 472,901 | 168,100 | — | 641,001 | ||||||||||||||
Other assets | — | 27,751 | 1,610 | 6,226 | — | 35,587 | ||||||||||||||
Total assets | $ | 515,816 | $ | 3,029,403 | $ | 3,337,897 | $ | 538,949 | $ | (5,325,031 | ) | $ | 2,097,034 | |||||||
Liabilities and Stockholders’ (Deficit) Equity | ||||||||||||||||||||
Accounts payable | $ | 6 | $ | — | $ | 207,454 | $ | 57,313 | $ | — | $ | 264,773 | ||||||||
Due to affiliates | 772,232 | 697,914 | 447 | 70,172 | (1,540,765 | ) | — | |||||||||||||
Accrued liabilities | 559 | 12,876 | 122,182 | 25,013 | — | 160,630 | ||||||||||||||
Income taxes payable | — | 1,120 | 1 | 2,603 | — | 3,724 | ||||||||||||||
Long-term debt | — | 1,807,213 | 223 | 3,556 | — | 1,810,992 | ||||||||||||||
Other liabilities | — | — | 26,069 | 2,834 | — | 28,903 | ||||||||||||||
Deferred income tax liabilities, net | (1,425 | ) | (300 | ) | 88,622 | (3,329 | ) | — | 83,568 | |||||||||||
Total liabilities | 771,372 | 2,518,823 | 444,998 | 158,162 | (1,540,765 | ) | 2,352,590 | |||||||||||||
Total stockholders’ (deficit) equity | (255,556 | ) | 510,580 | 2,892,899 | 380,787 | (3,784,266 | ) | (255,556 | ) | |||||||||||
Total liabilities and stockholders’ (deficit) equity | $ | 515,816 | $ | 3,029,403 | $ | 3,337,897 | $ | 538,949 | $ | (5,325,031 | ) | $ | 2,097,034 | |||||||
Condensed Consolidating Balance Sheet | ||||||||||||||||||||
September 30, 2014 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
Holdings | Subsidiaries | Guarantor | Eliminations | Holdings, | ||||||||||||||||
LLC and | Subsidiaries | Inc. and | ||||||||||||||||||
Sally Capital | Subsidiaries | |||||||||||||||||||
Inc. | ||||||||||||||||||||
Assets | ||||||||||||||||||||
Cash and cash equivalents | $ | — | $ | 27,000 | $ | 40,042 | $ | 39,533 | $ | — | $ | 106,575 | ||||||||
Trade and other accounts receivable, less allowance for doubtful accounts | 2 | — | 63,009 | 35,489 | — | 98,500 | ||||||||||||||
Due from affiliates | — | — | 1,464,752 | 27 | (1,464,779 | ) | — | |||||||||||||
Inventory | — | — | 631,786 | 196,643 | — | 828,429 | ||||||||||||||
Other current assets | 7,935 | 452 | 15,016 | 15,592 | — | 38,995 | ||||||||||||||
Deferred income tax assets, net | (213 | ) | 1 | 30,527 | 1,335 | — | 31,650 | |||||||||||||
Property and equipment, net | 1 | — | 158,402 | 79,708 | — | 238,111 | ||||||||||||||
Investment in subsidiaries | 471,320 | 2,835,722 | 392,270 | — | (3,699,312 | ) | — | |||||||||||||
Goodwill and other intangible assets, net | — | — | 476,113 | 174,972 | — | 651,085 | ||||||||||||||
Other assets | — | 28,931 | 1,625 | 6,072 | — | 36,628 | ||||||||||||||
Total assets | $ | 479,045 | $ | 2,892,106 | $ | 3,273,542 | $ | 549,371 | $ | (5,164,091 | ) | $ | 2,029,973 | |||||||
Liabilities and Stockholders’ (Deficit) Equity | ||||||||||||||||||||
Accounts payable | $ | — | $ | — | $ | 202,743 | $ | 56,720 | $ | — | $ | 259,463 | ||||||||
Due to affiliates | 826,819 | 571,847 | 27 | 66,086 | (1,464,779 | ) | — | |||||||||||||
Accrued liabilities | 691 | 40,751 | 129,791 | 27,536 | — | 198,769 | ||||||||||||||
Income taxes payable | — | 1,051 | 1 | 3,279 | — | 4,331 | ||||||||||||||
Long-term debt | — | 1,807,447 | 267 | 3,927 | — | 1,811,641 | ||||||||||||||
Other liabilities | — | — | 25,020 | 2,828 | — | 27,848 | ||||||||||||||
Deferred income tax liabilities, net | (1,412 | ) | (310 | ) | 79,971 | (3,275 | ) | — | 74,974 | |||||||||||
Total liabilities | 826,098 | 2,420,786 | 437,820 | 157,101 | (1,464,779 | ) | 2,377,026 | |||||||||||||
Total stockholders’ (deficit) equity | (347,053 | ) | 471,320 | 2,835,722 | 392,270 | (3,699,312 | ) | (347,053 | ) | |||||||||||
Total liabilities and stockholders’ (deficit) equity | $ | 479,045 | $ | 2,892,106 | $ | 3,273,542 | $ | 549,371 | $ | (5,164,091 | ) | $ | 2,029,973 | |||||||
Schedule of Condensed Consolidating Statement of Earnings | ||||||||||||||||||||
Condensed Consolidating Statement of Earnings and Comprehensive Income | ||||||||||||||||||||
Three Months Ended December 31, 2014 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally Holdings | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
LLC and Sally | Subsidiaries | Guarantor | Eliminations | Holdings, Inc. | ||||||||||||||||
Capital Inc. | Subsidiaries | and Subsidiaries | ||||||||||||||||||
Net sales | $ | — | $ | — | $ | 767,923 | $ | 196,545 | $ | — | $ | 964,468 | ||||||||
Related party sales | — | — | 767 | — | (767 | ) | — | |||||||||||||
Cost of products sold and distribution expenses | — | — | 386,816 | 104,650 | (767 | ) | 490,699 | |||||||||||||
Gross profit | — | — | 381,874 | 91,895 | — | 473,769 | ||||||||||||||
Selling, general and administrative expenses | 2,376 | 104 | 257,786 | 76,688 | — | 336,954 | ||||||||||||||
Depreciation and amortization | — | — | 14,854 | 5,725 | — | 20,579 | ||||||||||||||
Operating earnings (loss) | (2,376 | ) | (104 | ) | 109,234 | 9,482 | — | 116,236 | ||||||||||||
Interest expense | — | 29,193 | 2 | 46 | — | 29,241 | ||||||||||||||
Earnings (loss) before provision for income taxes | (2,376 | ) | (29,297 | ) | 109,232 | 9,436 | — | 86,995 | ||||||||||||
Provision (benefit) for income taxes | (724 | ) | (11,379 | ) | 40,872 | 3,317 | — | 32,086 | ||||||||||||
Equity in earnings of subsidiaries, net of tax | 56,561 | 74,479 | 6,119 | — | (137,159 | ) | — | |||||||||||||
Net earnings | 54,909 | 56,561 | 74,479 | 6,119 | (137,159 | ) | 54,909 | |||||||||||||
Other comprehensive income (loss), net of tax | — | — | — | (17,301 | ) | — | (17,301 | ) | ||||||||||||
Total comprehensive income (loss) | $ | 54,909 | $ | 56,561 | $ | 74,479 | $ | (11,182 | ) | $ | (137,159 | ) | $ | 37,608 | ||||||
Condensed Consolidating Statement of Earnings and Comprehensive Income | ||||||||||||||||||||
Three Months Ended December 31, 2013 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally Holdings | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
LLC and Sally | Subsidiaries | Guarantor | Eliminations | Holdings, Inc. | ||||||||||||||||
Capital Inc. | Subsidiaries | and Subsidiaries | ||||||||||||||||||
Net sales | $ | — | $ | — | $ | 743,276 | $ | 197,188 | $ | — | $ | 940,464 | ||||||||
Related party sales | — | — | 803 | — | (803 | ) | — | |||||||||||||
Cost of products sold and distribution expenses | — | — | 374,681 | 106,060 | (803 | ) | 479,938 | |||||||||||||
Gross profit | — | — | 369,398 | 91,128 | — | 460,526 | ||||||||||||||
Selling, general and administrative expenses | 2,463 | 112 | 241,881 | 75,022 | — | 319,478 | ||||||||||||||
Depreciation and amortization | — | — | 13,870 | 5,385 | — | 19,255 | ||||||||||||||
Operating earnings (loss) | (2,463 | ) | (112 | ) | 113,647 | 10,721 | — | 121,793 | ||||||||||||
Interest expense | — | 28,425 | 1 | 63 | — | 28,489 | ||||||||||||||
Earnings (loss) before provision for income taxes | (2,463 | ) | (28,537 | ) | 113,646 | 10,658 | — | 93,304 | ||||||||||||
Provision (benefit) for income taxes | (932 | ) | (11,080 | ) | 43,980 | 3,341 | — | 35,309 | ||||||||||||
Equity in earnings of subsidiaries, net of tax | 59,526 | 76,983 | 7,317 | — | (143,826 | ) | — | |||||||||||||
Net earnings | 57,995 | 59,526 | 76,983 | 7,317 | (143,826 | ) | 57,995 | |||||||||||||
Other comprehensive income, net of tax | — | — | — | 2,567 | — | 2,567 | ||||||||||||||
Total comprehensive income | $ | 57,995 | $ | 59,526 | $ | 76,983 | $ | 9,884 | $ | (143,826 | ) | $ | 60,562 | |||||||
Schedule of Condensed Consolidating Statement of Cash Flows | ||||||||||||||||||||
Condensed Consolidating Statement of Cash Flows | ||||||||||||||||||||
Three months ended December 31, 2014 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally Holdings | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
LLC and | Subsidiaries | Guarantor | Eliminations | Holdings, | ||||||||||||||||
Sally Capital | Subsidiaries | Inc. and | ||||||||||||||||||
Inc. | Subsidiaries | |||||||||||||||||||
Net cash (used) provided by operating activities | $ | (46,946 | ) | $ | 80,501 | $ | 12,356 | $ | 11,125 | $ | — | $ | 57,036 | |||||||
Cash Flows from Investing Activities: | ||||||||||||||||||||
Capital expenditures, net of proceeds from sale of property and equipment | — | — | (11,915 | ) | (6,885 | ) | — | (18,800 | ) | |||||||||||
Net cash used by investing activities | — | — | (11,915 | ) | (6,885 | ) | — | (18,800 | ) | |||||||||||
Cash Flows from Financing Activities: | ||||||||||||||||||||
Repayments of long-term debt | — | — | (43 | ) | (215 | ) | — | (258 | ) | |||||||||||
Repurchases of common stock | (7,253 | ) | — | — | — | — | (7,253 | ) | ||||||||||||
Proceeds from exercises of stock options | 37,156 | — | — | — | — | 37,156 | ||||||||||||||
Excess tax benefit from share-based compensation | 17,043 | — | — | — | — | 17,043 | ||||||||||||||
Net cash provided (used) by financing activities | 46,946 | — | (43 | ) | (215 | ) | — | 46,688 | ||||||||||||
Effect of foreign exchange rate changes on cash and cash equivalents | — | — | — | (818 | ) | — | (818 | ) | ||||||||||||
Net increase in cash and cash equivalents | — | 80,501 | 398 | 3,207 | — | 84,106 | ||||||||||||||
Cash and cash equivalents, beginning of period | — | 27,000 | 40,042 | 39,533 | — | 106,575 | ||||||||||||||
Cash and cash equivalents, end of period | $ | — | $ | 107,501 | $ | 40,440 | $ | 42,740 | $ | — | $ | 190,681 | ||||||||
Condensed Consolidating Statement of Cash Flows | ||||||||||||||||||||
Three Months Ended December 31, 2013 | ||||||||||||||||||||
(In thousands) | ||||||||||||||||||||
Parent | Sally Holdings | Guarantor | Non- | Consolidating | Sally Beauty | |||||||||||||||
LLC and | Subsidiaries | Guarantor | Eliminations | Holdings, | ||||||||||||||||
Sally Capital | Subsidiaries | Inc. and | ||||||||||||||||||
Inc. | Subsidiaries | |||||||||||||||||||
Net cash provided (used) by operating activities | $ | 55,879 | $ | (41,111 | ) | $ | 34,374 | $ | 10,962 | $ | — | $ | 60,104 | |||||||
Cash Flows from Investing Activities: | ||||||||||||||||||||
Capital expenditures, net of proceeds from sale of property and equipment | — | — | (7,766 | ) | (5,609 | ) | — | (13,375 | ) | |||||||||||
Net cash used by investing activities | — | — | (7,766 | ) | (5,609 | ) | — | (13,375 | ) | |||||||||||
Cash Flows from Financing Activities: | ||||||||||||||||||||
Proceeds from issuance of long-term debt | — | 232,500 | 219 | — | — | 232,719 | ||||||||||||||
Repayments of long-term debt | — | (108,500 | ) | (39 | ) | (486 | ) | — | (109,025 | ) | ||||||||||
Debt issuance costs | — | (3,888 | ) | — | — | — | (3,888 | ) | ||||||||||||
Repurchases of common stock | (66,183 | ) | — | — | — | — | (66,183 | ) | ||||||||||||
Proceeds from exercises of stock options | 7,319 | — | — | — | — | 7,319 | ||||||||||||||
Excess tax benefit from share-based compensation | 2,985 | — | — | — | — | 2,985 | ||||||||||||||
Net cash (used) provided by financing activities | (55,879 | ) | 120,112 | 180 | (486 | ) | — | 63,927 | ||||||||||||
Effect of foreign exchange rate changes on cash and cash equivalents | — | — | — | 153 | — | 153 | ||||||||||||||
Net increase in cash and cash equivalents | — | 79,001 | 26,788 | 5,020 | — | 110,809 | ||||||||||||||
Cash and cash equivalents, beginning of period | — | — | 16,337 | 30,778 | — | 47,115 | ||||||||||||||
Cash and cash equivalents, end of period | $ | — | $ | 79,001 | $ | 43,125 | $ | 35,798 | $ | — | $ | 157,924 | ||||||||
Fair_Value_Measurements_Detail
Fair Value Measurements (Details) (USD $) | Dec. 31, 2014 | Sep. 30, 2014 |
In Thousands, unless otherwise specified | ||
Liabilities | ||
Long-term debt, amortized cost | $1,810,992 | $1,811,641 |
Fair value measurement on recurring basis | Total | ||
Assets | ||
Cash equivalents | 107,501 | 27,000 |
Total assets | 108,785 | 27,511 |
Liabilities | ||
Long-term debt | 1,893,779 | 1,874,444 |
Total liabilities | 1,893,782 | 1,874,491 |
Fair value measurement on recurring basis | Foreign exchange contracts | Total | ||
Assets | ||
Foreign exchange derivative | 1,284 | 511 |
Liabilities | ||
Foreign exchange derivative | 3 | 47 |
Fair value measurement on recurring basis | Level 1 | ||
Assets | ||
Cash equivalents | 107,501 | 27,000 |
Total assets | 107,501 | 27,000 |
Liabilities | ||
Long-term debt | 1,890,000 | 1,870,250 |
Total liabilities | 1,890,000 | 1,870,250 |
Fair value measurement on recurring basis | Level 2 | ||
Assets | ||
Total assets | 1,284 | 511 |
Liabilities | ||
Long-term debt | 3,779 | 4,194 |
Total liabilities | 3,782 | 4,241 |
Fair value measurement on recurring basis | Level 2 | Foreign exchange contracts | ||
Assets | ||
Foreign exchange derivative | 1,284 | 511 |
Liabilities | ||
Foreign exchange derivative | $3 | $47 |
Accumulated_Stockholders_Equit1
Accumulated Stockholders' Equity (Deficit) (Details) (USD $) | 1 Months Ended | 3 Months Ended | |
Share data in Millions, unless otherwise specified | Aug. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 |
2014 Share Repurchase Program | |||
Share repurchase program | |||
Amount of shares authorized to be repurchased | $1,000,000,000 | ||
Term of share repurchase program | 3 years | ||
Common stock shares repurchased and retired (in shares) | 0.2 | ||
Cost of repurchase and retirement of common stock | 7,300,000 | ||
2013 Share Repurchase Program | |||
Share repurchase program | |||
Common stock shares repurchased and retired (in shares) | 2.4 | ||
Cost of repurchase and retirement of common stock | $66,200,000 |
Accumulated_Stockholders_Equit2
Accumulated Stockholders' Equity (Deficit) (Details 2) (USD $) | 3 Months Ended | 12 Months Ended |
Dec. 31, 2014 | Sep. 30, 2014 | |
Accumulated Stockholders' Equity (Deficit) | ||
Accumulated other comprehensive loss | ($45,849,000) | ($28,548,000) |
Foreign currency translation adjustments | ||
Accumulated Stockholders' Equity (Deficit) | ||
Accumulated other comprehensive loss | 45,800,000 | 28,500,000 |
Income taxes on accumulated other comprehensive loss | $2,300,000 | $2,300,000 |
Earnings_Per_Share_Details
Earnings Per Share (Details) (USD $) | 3 Months Ended | |
In Thousands, except Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Net earnings | $54,909 | $57,995 |
Total weighted average basic shares | 156,104,000 | 163,603,000 |
Dilutive securities: | ||
Stock options and stock award programs (in shares) | 2,441,000 | 4,152,000 |
Total weighted average diluted shares | 158,545,000 | 167,755,000 |
Earnings per share: | ||
Basic (in dollars per share) | $0.35 | $0.35 |
Diluted (in dollars per share) | $0.35 | $0.35 |
Common stock potentially outstanding but not included in the computation of diluted earnings per share | ||
Options to purchase shares not included in the computation of diluted earnings per share since the options were anti-dilutive (in shares) | 1,259,204 | 1,462,543 |
ShareBased_Payments_Details
Share-Based Payments (Details) (USD $) | 3 Months Ended | 12 Months Ended | |
Share data in Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2014 |
Share-Based Payments | |||
Accelerated expense related to certain retirement eligible employees (in dollars) | $4,800,000 | 5,300,000 | |
Share-based compensation expense (in dollars) | 7,760,000 | 8,522,000 | |
Income tax benefit related to share-based compensation expense (in dollars) | 2,918,000 | 3,181,000 | |
Stock Option Awards | |||
Share-Based Payments | |||
Vesting period | 4 years | ||
Stock Options, Number of Outstanding Options | |||
Outstanding at the beginning of the period (in shares) | 8,983 | ||
Granted (in shares) | 1,132 | 1,500 | |
Exercised (in shares) | -3,265 | ||
Forfeited or expired (in shares) | -33 | ||
Outstanding at the end of the period (in shares) | 6,817 | 8,983 | |
Exercisable at the end of the period (in shares) | 3,405 | ||
Stock Options, Additional Information | |||
Outstanding at the beginning of the period (in dollars per share) | $15.93 | ||
Granted (in dollars per share) | $29.20 | ||
Exercised (in dollars per share) | $11.38 | ||
Forfeited or expired (in dollars per share) | $22.64 | ||
Outstanding at the end of the period (in dollars per share) | $20.28 | $15.93 | |
Exercisable at the end of the period (in dollars per share) | $14.78 | ||
Outstanding at the beginning of the period | 7 years 1 month 6 days | 6 years 2 months 12 days | |
Outstanding at the end of the period | 7 years 1 month 6 days | 6 years 2 months 12 days | |
Exercisable at the end of the period | 5 years 6 months | ||
Outstanding at the beginning of the period (in dollars) | 102,751,000 | ||
Outstanding at the end of the period (in dollars) | 71,282,000 | 102,751,000 | |
Exercisable at the end of the period (in dollars) | $54,366,000 | ||
Stock Option Awards | Maximum | |||
Share-Based Payments | |||
Term of stock options | 10 years |
ShareBased_Payments_Details_2
Share-Based Payments (Details 2) (USD $) | 3 Months Ended |
In Thousands, except Per Share data, unless otherwise specified | Dec. 31, 2014 |
Options Outstanding | |
Range of Exercise Prices, Number Outstanding (in shares) | 6,817 |
Range of Exercise Prices, Weighted Average Remaining Contractual Term | 7 years 1 month 6 days |
Range of Exercise Prices, Weighted Average Exercise Price (in dollars per share) | $20.28 |
Options Exercisable | |
Range of Exercise Prices, Number Exercisable (in shares) | 3,405 |
Range of Exercise Prices, Weighted Average Exercise Price (in dollars per share) | $14.78 |
Range of Exercise Prices $2.00 - 19.99 | |
Information about stock options under option plans | |
Lower Range of Exercise Prices (in dollars per share) | $2 |
Upper Range of Exercise Prices (in dollars per share) | $19.99 |
Options Outstanding | |
Range of Exercise Prices, Number Outstanding (in shares) | 3,026 |
Range of Exercise Prices, Weighted Average Remaining Contractual Term | 5 years |
Range of Exercise Prices, Weighted Average Exercise Price (in dollars per share) | $12.79 |
Options Exercisable | |
Range of Exercise Prices, Number Exercisable (in shares) | 2,617 |
Range of Exercise Prices, Weighted Average Exercise Price (in dollars per share) | $11.78 |
Range of Exercise Prices $20.00 - 29.20 | |
Information about stock options under option plans | |
Lower Range of Exercise Prices (in dollars per share) | $20 |
Upper Range of Exercise Prices (in dollars per share) | $29.20 |
Options Outstanding | |
Range of Exercise Prices, Number Outstanding (in shares) | 3,791 |
Range of Exercise Prices, Weighted Average Remaining Contractual Term | 8 years 8 months 12 days |
Range of Exercise Prices, Weighted Average Exercise Price (in dollars per share) | $26.27 |
Options Exercisable | |
Range of Exercise Prices, Number Exercisable (in shares) | 788 |
Range of Exercise Prices, Weighted Average Exercise Price (in dollars per share) | $24.70 |
ShareBased_Payments_Details_3
Share-Based Payments (Details 3) (USD $) | 3 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Stock option disclosures | ||
Cash received from option exercised | $37,156,000 | $7,319,000 |
Stock Option Awards | ||
Weighted average assumptions relating to the valuation of stock options | ||
Expected life | 5 years | 5 years |
Expected volatility (as a percent) | 31.00% | 48.40% |
Risk-free interest rate (as a percent) | 1.60% | 1.30% |
Dividend yield (as a percent) | 0.00% | 0.00% |
Stock option disclosures | ||
Weighted average fair value of the stock options issued (in dollars per share) | $8.77 | $11.32 |
Total intrinsic value of options exercised | 61,500,000 | |
Cash received from option exercised | 37,200,000 | |
Tax benefit realized for the tax deductions of stock option exercises | 23,400,000 | |
Total unrecognized compensation costs related to unvested stock option awards | $18,000,000 | |
Weighted average period for recognition of unvested awards | 2 years 7 months 6 days |
ShareBased_Payments_Details_4
Share-Based Payments (Details 4) (USD $) | 3 Months Ended | 12 Months Ended | |
In Millions, except Share data, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2014 |
Restricted Stock Awards | |||
Summary of the activity for restricted stock awards/restricted stock units, Number of Shares | |||
Unvested at the beginning of the period (in shares) | 436,000 | ||
Granted (in shares) | 214,000 | 25,000 | |
Vested (in shares) | -83,000 | ||
Unvested at the end of the period (in shares) | 567,000 | 436,000 | |
Restricted stock awards/restricted stock units | |||
Unvested at the beginning of the period (in dollars per share) | $22.42 | ||
Granted (in dollars per share) | $29.20 | ||
Vested (in dollars per share) | $14.30 | ||
Unvested at the end of the period (in dollars per share) | $26.16 | $22.42 | |
Weighted average remaining vesting term | 3 years 2 months 12 days | 3 years 4 months 24 days | |
Total unrecognized compensation costs | $6.80 | ||
Weighted average period for recognition of unvested restricted awards | 3 years 2 months 12 days | ||
Restricted Stock Awards | Minimum | |||
Stock Awards | |||
Vesting period | 4 years | ||
Restricted Stock Awards | Maximum | |||
Stock Awards | |||
Vesting period | 5 years | ||
Restricted Stock Units | |||
Stock Awards | |||
Vesting period | 1 year | ||
Summary of the activity for restricted stock awards/restricted stock units, Number of Shares | |||
Granted (in shares) | 20,000 | 27,000 | |
Unvested at the end of the period (in shares) | 20,000 | ||
Restricted stock awards/restricted stock units | |||
Granted (in dollars per share) | $29.20 | ||
Unvested at the end of the period (in dollars per share) | $29.20 | ||
Weighted average remaining vesting term | 9 months 18 days | ||
Total unrecognized compensation costs | $0.50 | ||
Weighted average period for recognition of unvested restricted awards | 9 months 18 days | ||
Restricted stock units, retention period | 6 months | ||
Restricted Stock Units | Maximum | |||
Stock Awards | |||
Vesting period | 1 year |
Commitments_and_Contingencies1
Commitments and Contingencies (Data Security Incident, USD $) | 3 Months Ended |
In Millions, unless otherwise specified | Dec. 31, 2014 |
Data Security Incident | |
Commitments and contingencies | |
Professional advisory and legal costs included in selling, general and administrative expenses | $0.20 |
Recovered_Sheet1
Short-term Borrowings and Long-term Debt (Details) (USD $) | 3 Months Ended | 12 Months Ended | 0 Months Ended | 12 Months Ended | ||||
Dec. 31, 2014 | Dec. 31, 2013 | Sep. 30, 2012 | Oct. 29, 2013 | Sep. 30, 2011 | Sep. 30, 2014 | Nov. 30, 2006 | Jul. 31, 2013 | |
Debt Instruments | ||||||||
Total | $1,807,264,000 | |||||||
Capital lease obligations | 3,728,000 | |||||||
Less: current portion | 888,000 | 974,000 | ||||||
Total long-term debt | 1,810,104,000 | 1,810,667,000 | ||||||
Aggregate principal amount of debt retired | 1,391,900,000 | |||||||
Net proceeds from debt issuance | 232,719,000 | |||||||
Borrowings repaid | 258,000 | 109,025,000 | ||||||
Sally Investment Holdings LLC and Sally Holdings, LLC | ||||||||
Debt Instruments | ||||||||
Debt Instrument, Face Amount | 1,850,000,000 | |||||||
ABL facility | ||||||||
Debt Instruments | ||||||||
Revolving credit facility | 500,000,000 | |||||||
Remaining credit facility available | 478,100,000 | |||||||
Commitment fee for line of credit facility (as a percent) | 0.25% | |||||||
Borrowings repaid | 88,500,000 | |||||||
ABL facility | Prime | Minimum | ||||||||
Debt Instruments | ||||||||
Percentage points added to the reference rate | 0.50% | |||||||
ABL facility | Prime | Maximum | ||||||||
Debt Instruments | ||||||||
Percentage points added to the reference rate | 0.75% | |||||||
ABL facility | LIBOR | Minimum | ||||||||
Debt Instruments | ||||||||
Percentage points added to the reference rate | 1.50% | |||||||
ABL facility | LIBOR | Maximum | ||||||||
Debt Instruments | ||||||||
Percentage points added to the reference rate | 1.75% | |||||||
ABL facility | Sally Holdings, LLC | ||||||||
Debt Instruments | ||||||||
Revolving credit facility | 400,000,000 | |||||||
Line of Credit Facility Term | 5 years | |||||||
Canadian sub-facility | ||||||||
Debt Instruments | ||||||||
Revolving credit facility | 25,000,000 | |||||||
Senior notes due Nov. 2019 | ||||||||
Debt Instruments | ||||||||
Total | 750,000,000 | |||||||
Interest rate (as a percent) | 6.88% | 6.88% | ||||||
Debt Instrument, Face Amount | 750,000,000 | |||||||
Senior notes due Jun. 2022 | ||||||||
Debt Instruments | ||||||||
Total | 857,213,000 | |||||||
Interest rate (as a percent) | 5.75% | 5.75% | ||||||
Debt Instrument, Face Amount | 850,000,000 | |||||||
Senior notes due Jun. 2022 | Maximum | ||||||||
Debt Instruments | ||||||||
Maximum percentage of original principal amount that can be redeemed from specified proceeds | 35.00% | |||||||
Senior notes due 2022 issued for $150 million | ||||||||
Debt Instruments | ||||||||
Unamortized premium | 7,200,000 | |||||||
Debt Instrument, Face Amount | 150,000,000 | 150,000,000 | ||||||
Senior notes due 2022 issued for $850 million | ||||||||
Debt Instruments | ||||||||
Interest rate (as a percent) | 5.75% | |||||||
Debt Instrument, Face Amount | 850,000,000 | |||||||
Senior notes due Nov. 2023 | ||||||||
Debt Instruments | ||||||||
Total | 200,000,000 | |||||||
Interest rate (as a percent) | 5.50% | 5.50% | ||||||
Debt Instrument, Face Amount | 200,000,000 | |||||||
Net proceeds from debt issuance | 196,300,000 | |||||||
Maximum percentage of original principal amount that can be redeemed from specified proceeds | 35.00% | |||||||
Other, due Jun. 2015 | ||||||||
Debt Instruments | ||||||||
Total | $51,000 | |||||||
Interest rate (as a percent) | 5.79% |
Recovered_Sheet2
Short-term Borrowings and Long-term Debt (Details 2) (USD $) | 3 Months Ended | ||||
Dec. 31, 2014 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Jul. 31, 2013 | |
Fiscal Year: | |||||
2015 | $51,000 | ||||
2019 | 750,000,000 | ||||
Thereafter | 1,057,213,000 | ||||
Total | 1,807,264,000 | ||||
Capital lease obligations | 3,728,000 | ||||
Less: current portion | 888,000 | 974,000 | |||
Total long-term debt | 1,810,104,000 | 1,810,667,000 | |||
Cash and cash equivalents | 190,681,000 | 106,575,000 | 157,924,000 | 47,115,000 | |
ABL facility | |||||
Fiscal Year: | |||||
Secured Leverage Ratio, threshold | 4 | ||||
Minimum borrowing availability | 40,000,000 | ||||
Percentage of borrowing base | 10.00% | ||||
Consolidated Fixed-Charge Coverage Ratio, threshold | 1 | ||||
Consolidated Fixed-Charge Coverage Ratio | 3.4 | ||||
Revolving credit facility borrowing availability | 500,000,000 | ||||
ABL facility | Maximum | |||||
Fiscal Year: | |||||
Secured Leverage Ratio | 0.1 | ||||
ABL facility | Restricted payments up to $30.0 million | |||||
Fiscal Year: | |||||
Restricted payments | 30,000,000 | ||||
Minimum borrowing availability | 75,000,000 | ||||
Percentage of borrowing base | 15.00% | ||||
Period prior to payments of dividends and other equity distributions up to certain thresholds under the terms of the credit facility must be met | 45 days | ||||
ABL facility | Restricted payments in excess of $30.0 million | |||||
Fiscal Year: | |||||
Minimum borrowing availability | 100,000,000 | ||||
Percentage of borrowing base | 20.00% | ||||
Period prior to payments of dividends and other equity distributions up to certain thresholds under the terms of the credit facility must be met | 45 days | ||||
Consolidated Fixed-Charge Coverage Ratio, threshold | 1.1 | ||||
Revolving credit facility borrowing availability | 150,000,000 | ||||
Percentage of lesser of $150.0 million or borrowing base, considered for applicability of Consolidated Fixed Charge Coverage Ratio | 0.3 | ||||
Trailing period preceding proposed Restricted Payment | 12 months | ||||
Senior notes due 2019, 2022 and 2023 | |||||
Fiscal Year: | |||||
Consolidated Coverage Ratio, threshold | 2 | ||||
Consolidated Coverage Ratio | 5.5 | ||||
Number of consecutive fiscal quarters | 4 | ||||
Percentage of Sally Holdings and its subsidiaries cumulative consolidated net earnings | 50.00% | ||||
Consolidated Total Leverage Ratio, threshold | 3.25 | ||||
Consolidated Total Leverage Ratio | 2.8 | ||||
Senior notes due 2019, 2022 and 2023 | Maximum | |||||
Fiscal Year: | |||||
Cash and cash equivalents | $100,000,000 |
Derivative_Instruments_and_Hed2
Derivative Instruments and Hedging Activities (Details) | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2013 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 | Dec. 31, 2014 |
derivative | Foreign exchange contracts | Foreign exchange contracts | USD:UKPounds | USD:UKPounds | USD:UKPounds | USD:UKPounds | USD:EUR | USD:EUR | USD:EUR | USD:EUR | USD:CAD | USD:CAD | CAD:USD | CAD:USD | USD:MXN | USD:MXN | UKPounds:EUR | UKPounds:EUR | |
USD ($) | USD ($) | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | Foreign exchange contracts | ||
Sale | Sale | Purchase | Purchase | Sale | Sale | Sale | Sale | Sale | Sale | Purchase | Purchase | Sale | Sale | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | ||||
Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Derivatives not designated as hedging instruments | Cash flow hedges resulting from the sale of products and services among European subsidiaries | Cash flow hedges resulting from the sale of products and services among European subsidiaries | ||||
Cash flow hedges to manage exposure of international subsidiaries purchases | Cash flow hedges to manage exposure of international subsidiaries purchases | Cash flow hedges in connection with intercompany balances | Cash flow hedges in connection with intercompany balances | Cash flow hedges to manage exposure of international subsidiaries purchases | Cash flow hedges to manage exposure of international subsidiaries purchases | Cash flow hedges in connection with intercompany balances | Cash flow hedges in connection with intercompany balances | Cash flow hedges in connection with intercompany balances | Cash flow hedges in connection with intercompany balances | Cash flow hedges in connection with intercompany balances | Cash flow hedges in connection with intercompany balances | Cash flow hedges in connection with intercompany balances | Cash flow hedges in connection with intercompany balances | USD ($) | GBP (£) | ||||
USD ($) | GBP (£) | USD ($) | GBP (£) | USD ($) | EUR (€) | USD ($) | EUR (€) | USD ($) | CAD | USD ($) | CAD | USD ($) | MXN | ||||||
Derivative Instruments | |||||||||||||||||||
Notional amount | $7,600,000 | £ 4,900,000 | $1,800,000 | £ 1,100,000 | $10,600,000 | € 8,800,000 | $21,900,000 | € 18,100,000 | $4,500,000 | 5,200,000 | $13,400,000 | 15,600,000 | $2,100,000 | 30,700,000 | $3,500,000 | £ 2,300,000 | |||
Designated Cash Flow Hedges | |||||||||||||||||||
Number of derivative instruments held | 0 | ||||||||||||||||||
Non-designated Cash Flow Hedges | |||||||||||||||||||
Contractual exchange rate (as a percent) | 1.5511 | 1.5511 | 1.2183 | 1.2183 | 1.1621 | 1.1621 | 1.1664 | 1.1664 | 14.779 | 14.779 | |||||||||
Net gains (losses) included in selling, general and administrative expenses | $1,504,000 | ($858,000) | |||||||||||||||||
Weighted average contractual exchange rate for buy contracts (as a percent) | 1.6268 | 1.6268 | 1.2908 | 1.2908 | 0.7984 | 0.7984 |
Derivative_Instruments_and_Hed3
Derivative Instruments and Hedging Activities (Details 2) (USD $) | Dec. 31, 2014 | Sep. 30, 2014 |
In Thousands, unless otherwise specified | ||
Derivatives Not Designated as Hedging Instruments | ||
Total derivatives not designated as hedging instruments, Asset | $1,284 | $511 |
Total derivatives not designated as hedging instruments, Liability | 3 | 47 |
Other current assets | ||
Derivatives Not Designated as Hedging Instruments | ||
Foreign Exchange Contracts, Asset | 1,284 | 511 |
Accrued liabilities | ||
Derivatives Not Designated as Hedging Instruments | ||
Foreign Exchange Contracts, Liability | $3 | $47 |
Derivative_Instruments_and_Hed4
Derivative Instruments and Hedging Activities (Details 3) (USD $) | 3 Months Ended | |
Dec. 31, 2014 | Dec. 31, 2013 | |
Derivatives Designated as Hedging Instruments | ||
Amount of Gain or (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) | $0 | |
Credit-risk-related Contingent Features | ||
Probable loss on counterparty defaults | 0 | |
Foreign exchange contracts | ||
Derivatives Not Designated as Hedging Instruments | ||
Amount of Gain or (Loss) Recognized in Income on Derivatives, Foreign Exchange Contracts | 1,504,000 | -858,000 |
Credit-risk-related Contingent Features | ||
Aggregate maximum fair value of all foreign exchange contracts held in a liability position | $100,000 |
Business_Segments_Details
Business Segments (Details) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
segment | ||
Business Segments | ||
Number of operating segments | 2 | |
Net sales: | ||
Total net sales | $964,468 | $940,464 |
Segment operating profit: | ||
Total segment operating profit | 116,236 | 121,793 |
Share-based compensation expense | -7,760 | -8,522 |
Interest expense | -29,241 | -28,489 |
Earnings before provision for income taxes | 86,995 | 93,304 |
Operating segments | ||
Segment operating profit: | ||
Total segment operating profit | 157,768 | 158,377 |
Corporate | ||
Segment operating profit: | ||
Unallocated expenses | -33,772 | -28,062 |
Sally Beauty Supply | ||
Net sales: | ||
Total net sales | 586,519 | 573,355 |
Sally Beauty Supply | Operating segments | ||
Segment operating profit: | ||
Total segment operating profit | 101,179 | 103,543 |
Beauty Systems Group | ||
Net sales: | ||
Total net sales | 377,949 | 367,109 |
Beauty Systems Group | Operating segments | ||
Segment operating profit: | ||
Total segment operating profit | $56,589 | $54,834 |
Parent_Issuers_Guarantor_and_N2
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements (Details) (USD $) | Dec. 31, 2014 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 |
In Thousands, unless otherwise specified | ||||
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements | ||||
Percentage of guarantor subsidiaries owned by parent | 100.00% | |||
Assets | ||||
Cash and cash equivalents | $190,681 | $106,575 | $157,924 | $47,115 |
Trade and other accounts receivable, less allowance for doubtful accounts | 87,651 | 98,500 | ||
Inventory | 837,822 | 828,429 | ||
Other current assets | 35,868 | 38,995 | ||
Deferred income tax assets, net | 31,746 | 31,650 | ||
Property and equipment, net | 236,678 | 238,111 | ||
Goodwill and other intangible assets, net | 641,001 | 651,085 | ||
Other assets | 35,587 | 36,628 | ||
Total assets | 2,097,034 | 2,029,973 | ||
Liabilities and Stockholders' (Deficit) Equity | ||||
Accounts payable | 264,773 | 259,463 | ||
Accrued liabilities | 160,630 | 198,769 | ||
Income taxes payable | 3,724 | 4,331 | ||
Long-term debt | 1,810,992 | 1,811,641 | ||
Other liabilities | 28,903 | 27,848 | ||
Deferred income tax liabilities, net | 83,568 | 74,974 | ||
Total liabilities | 2,352,590 | 2,377,026 | ||
Total stockholders' (deficit) equity | -255,556 | -347,053 | ||
Total liabilities and stockholders' deficit | 2,097,034 | 2,029,973 | ||
Reportable Legal Entities | Parent | ||||
Assets | ||||
Trade and other accounts receivable, less allowance for doubtful accounts | 2 | |||
Other current assets | 5,448 | 7,935 | ||
Deferred income tax assets, net | -213 | -213 | ||
Property and equipment, net | 1 | 1 | ||
Investment in subsidiaries | 510,580 | 471,320 | ||
Total assets | 515,816 | 479,045 | ||
Liabilities and Stockholders' (Deficit) Equity | ||||
Accounts payable | 6 | |||
Due to affiliates | 772,232 | 826,819 | ||
Accrued liabilities | 559 | 691 | ||
Deferred income tax liabilities, net | -1,425 | -1,412 | ||
Total liabilities | 771,372 | 826,098 | ||
Total stockholders' (deficit) equity | -255,556 | -347,053 | ||
Total liabilities and stockholders' deficit | 515,816 | 479,045 | ||
Reportable Legal Entities | Sally Holdings LLC and Sally Capital Inc. | ||||
Assets | ||||
Cash and cash equivalents | 107,501 | 27,000 | 79,001 | |
Other current assets | 1,251 | 452 | ||
Deferred income tax assets, net | 1 | 1 | ||
Investment in subsidiaries | 2,892,899 | 2,835,722 | ||
Other assets | 27,751 | 28,931 | ||
Total assets | 3,029,403 | 2,892,106 | ||
Liabilities and Stockholders' (Deficit) Equity | ||||
Due to affiliates | 697,914 | 571,847 | ||
Accrued liabilities | 12,876 | 40,751 | ||
Income taxes payable | 1,120 | 1,051 | ||
Long-term debt | 1,807,213 | 1,807,447 | ||
Deferred income tax liabilities, net | -300 | -310 | ||
Total liabilities | 2,518,823 | 2,420,786 | ||
Total stockholders' (deficit) equity | 510,580 | 471,320 | ||
Total liabilities and stockholders' deficit | 3,029,403 | 2,892,106 | ||
Reportable Legal Entities | Guarantor Subsidiaries | ||||
Assets | ||||
Cash and cash equivalents | 40,440 | 40,042 | 43,125 | 16,337 |
Trade and other accounts receivable, less allowance for doubtful accounts | 58,231 | 63,009 | ||
Due from affiliates | 1,540,318 | 1,464,752 | ||
Inventory | 641,006 | 631,786 | ||
Other current assets | 13,115 | 15,016 | ||
Deferred income tax assets, net | 30,527 | 30,527 | ||
Property and equipment, net | 158,962 | 158,402 | ||
Investment in subsidiaries | 380,787 | 392,270 | ||
Goodwill and other intangible assets, net | 472,901 | 476,113 | ||
Other assets | 1,610 | 1,625 | ||
Total assets | 3,337,897 | 3,273,542 | ||
Liabilities and Stockholders' (Deficit) Equity | ||||
Accounts payable | 207,454 | 202,743 | ||
Due to affiliates | 447 | 27 | ||
Accrued liabilities | 122,182 | 129,791 | ||
Income taxes payable | 1 | 1 | ||
Long-term debt | 223 | 267 | ||
Other liabilities | 26,069 | 25,020 | ||
Deferred income tax liabilities, net | 88,622 | 79,971 | ||
Total liabilities | 444,998 | 437,820 | ||
Total stockholders' (deficit) equity | 2,892,899 | 2,835,722 | ||
Total liabilities and stockholders' deficit | 3,337,897 | 3,273,542 | ||
Reportable Legal Entities | Non-Guarantor Subsidiaries | ||||
Assets | ||||
Cash and cash equivalents | 42,740 | 39,533 | 35,798 | 30,778 |
Trade and other accounts receivable, less allowance for doubtful accounts | 29,420 | 35,489 | ||
Due from affiliates | 447 | 27 | ||
Inventory | 196,816 | 196,643 | ||
Other current assets | 16,054 | 15,592 | ||
Deferred income tax assets, net | 1,431 | 1,335 | ||
Property and equipment, net | 77,715 | 79,708 | ||
Goodwill and other intangible assets, net | 168,100 | 174,972 | ||
Other assets | 6,226 | 6,072 | ||
Total assets | 538,949 | 549,371 | ||
Liabilities and Stockholders' (Deficit) Equity | ||||
Accounts payable | 57,313 | 56,720 | ||
Due to affiliates | 70,172 | 66,086 | ||
Accrued liabilities | 25,013 | 27,536 | ||
Income taxes payable | 2,603 | 3,279 | ||
Long-term debt | 3,556 | 3,927 | ||
Other liabilities | 2,834 | 2,828 | ||
Deferred income tax liabilities, net | -3,329 | -3,275 | ||
Total liabilities | 158,162 | 157,101 | ||
Total stockholders' (deficit) equity | 380,787 | 392,270 | ||
Total liabilities and stockholders' deficit | 538,949 | 549,371 | ||
Consolidating Eliminations | ||||
Assets | ||||
Due from affiliates | -1,540,765 | -1,464,779 | ||
Investment in subsidiaries | -3,784,266 | -3,699,312 | ||
Total assets | -5,325,031 | -5,164,091 | ||
Liabilities and Stockholders' (Deficit) Equity | ||||
Due to affiliates | -1,540,765 | -1,464,779 | ||
Total liabilities | -1,540,765 | -1,464,779 | ||
Total stockholders' (deficit) equity | -3,784,266 | -3,699,312 | ||
Total liabilities and stockholders' deficit | ($5,325,031) | ($5,164,091) |
Parent_Issuers_Guarantor_and_N3
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements (Details 2) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Condensed Consolidating Statement of Earnings | ||
Net sales | $964,468 | $940,464 |
Cost of products sold and distribution expenses | 490,699 | 479,938 |
Gross profit | 473,769 | 460,526 |
Selling, general and administrative expenses | 336,954 | 319,478 |
Depreciation and amortization | 20,579 | 19,255 |
Operating earnings | 116,236 | 121,793 |
Interest expense | 29,241 | 28,489 |
Earnings before provision for income taxes | 86,995 | 93,304 |
Provision (benefit) for income taxes | 32,086 | 35,309 |
Net earnings | 54,909 | 57,995 |
Other comprehensive income (loss), net of tax | -17,301 | 2,567 |
Total comprehensive income | 37,608 | 60,562 |
Reportable Legal Entities | Parent | ||
Condensed Consolidating Statement of Earnings | ||
Selling, general and administrative expenses | 2,376 | 2,463 |
Operating earnings | -2,376 | -2,463 |
Earnings before provision for income taxes | -2,376 | -2,463 |
Provision (benefit) for income taxes | -724 | -932 |
Equity in earnings of subsidiaries, net of tax | 56,561 | 59,526 |
Net earnings | 54,909 | 57,995 |
Total comprehensive income | 54,909 | 57,995 |
Reportable Legal Entities | Sally Holdings LLC and Sally Capital Inc. | ||
Condensed Consolidating Statement of Earnings | ||
Selling, general and administrative expenses | 104 | 112 |
Operating earnings | -104 | -112 |
Interest expense | 29,193 | 28,425 |
Earnings before provision for income taxes | -29,297 | -28,537 |
Provision (benefit) for income taxes | -11,379 | -11,080 |
Equity in earnings of subsidiaries, net of tax | 74,479 | 76,983 |
Net earnings | 56,561 | 59,526 |
Total comprehensive income | 56,561 | 59,526 |
Reportable Legal Entities | Guarantor Subsidiaries | ||
Condensed Consolidating Statement of Earnings | ||
Net sales | 767,923 | 743,276 |
Related party sales | 767 | 803 |
Cost of products sold and distribution expenses | 386,816 | 374,681 |
Gross profit | 381,874 | 369,398 |
Selling, general and administrative expenses | 257,786 | 241,881 |
Depreciation and amortization | 14,854 | 13,870 |
Operating earnings | 109,234 | 113,647 |
Interest expense | 2 | 1 |
Earnings before provision for income taxes | 109,232 | 113,646 |
Provision (benefit) for income taxes | 40,872 | 43,980 |
Equity in earnings of subsidiaries, net of tax | 6,119 | 7,317 |
Net earnings | 74,479 | 76,983 |
Total comprehensive income | 74,479 | 76,983 |
Reportable Legal Entities | Non-Guarantor Subsidiaries | ||
Condensed Consolidating Statement of Earnings | ||
Net sales | 196,545 | 197,188 |
Cost of products sold and distribution expenses | 104,650 | 106,060 |
Gross profit | 91,895 | 91,128 |
Selling, general and administrative expenses | 76,688 | 75,022 |
Depreciation and amortization | 5,725 | 5,385 |
Operating earnings | 9,482 | 10,721 |
Interest expense | 46 | 63 |
Earnings before provision for income taxes | 9,436 | 10,658 |
Provision (benefit) for income taxes | 3,317 | 3,341 |
Net earnings | 6,119 | 7,317 |
Other comprehensive income (loss), net of tax | -17,301 | 2,567 |
Total comprehensive income | -11,182 | 9,884 |
Consolidating Eliminations | ||
Condensed Consolidating Statement of Earnings | ||
Related party sales | -767 | -803 |
Cost of products sold and distribution expenses | -767 | -803 |
Equity in earnings of subsidiaries, net of tax | -137,159 | -143,826 |
Net earnings | -137,159 | -143,826 |
Total comprehensive income | ($137,159) | ($143,826) |
Parent_Issuers_Guarantor_and_N4
Parent, Issuers, Guarantor and Non-Guarantor Condensed Consolidated Financial Statements (Details 3) (USD $) | 3 Months Ended | |
In Thousands, unless otherwise specified | Dec. 31, 2014 | Dec. 31, 2013 |
Condensed Consolidating Statement of Cash Flows | ||
Net cash (used) provided by operating activities | $57,036 | $60,104 |
Cash Flows from Investing Activities: | ||
Capital expenditures, net of proceeds from sale of property and equipment | -18,800 | -13,375 |
Net cash used by investing activities | -18,800 | -13,375 |
Cash Flows from Financing Activities: | ||
Proceeds from issuances of long-term debt | 232,719 | |
Repayments of long-term debt | -258 | -109,025 |
Debt issuance costs | -3,888 | |
Repurchases of common stock | -7,253 | -66,183 |
Proceeds from exercises of stock options | 37,156 | 7,319 |
Excess tax benefit from share-based compensation | 17,043 | 2,985 |
Net cash provided by financing activities | 46,688 | 63,927 |
Effect of foreign exchange rate changes on cash and cash equivalents | -818 | 153 |
Net increase in cash and cash equivalents | 84,106 | 110,809 |
Cash and cash equivalents, beginning of period | 106,575 | 47,115 |
Cash and cash equivalents, end of period | 190,681 | 157,924 |
Reportable Legal Entities | Parent | ||
Condensed Consolidating Statement of Cash Flows | ||
Net cash (used) provided by operating activities | -46,946 | 55,879 |
Cash Flows from Financing Activities: | ||
Repurchases of common stock | -7,253 | -66,183 |
Proceeds from exercises of stock options | 37,156 | 7,319 |
Excess tax benefit from share-based compensation | 17,043 | 2,985 |
Net cash provided by financing activities | 46,946 | -55,879 |
Reportable Legal Entities | Sally Holdings LLC and Sally Capital Inc. | ||
Condensed Consolidating Statement of Cash Flows | ||
Net cash (used) provided by operating activities | 80,501 | -41,111 |
Cash Flows from Financing Activities: | ||
Proceeds from issuances of long-term debt | 232,500 | |
Repayments of long-term debt | -108,500 | |
Debt issuance costs | -3,888 | |
Net cash provided by financing activities | 120,112 | |
Net increase in cash and cash equivalents | 80,501 | 79,001 |
Cash and cash equivalents, beginning of period | 27,000 | |
Cash and cash equivalents, end of period | 107,501 | 79,001 |
Reportable Legal Entities | Guarantor Subsidiaries | ||
Condensed Consolidating Statement of Cash Flows | ||
Net cash (used) provided by operating activities | 12,356 | 34,374 |
Cash Flows from Investing Activities: | ||
Capital expenditures, net of proceeds from sale of property and equipment | -11,915 | -7,766 |
Net cash used by investing activities | -11,915 | -7,766 |
Cash Flows from Financing Activities: | ||
Proceeds from issuances of long-term debt | 219 | |
Repayments of long-term debt | -43 | -39 |
Net cash provided by financing activities | -43 | 180 |
Net increase in cash and cash equivalents | 398 | 26,788 |
Cash and cash equivalents, beginning of period | 40,042 | 16,337 |
Cash and cash equivalents, end of period | 40,440 | 43,125 |
Reportable Legal Entities | Non-Guarantor Subsidiaries | ||
Condensed Consolidating Statement of Cash Flows | ||
Net cash (used) provided by operating activities | 11,125 | 10,962 |
Cash Flows from Investing Activities: | ||
Capital expenditures, net of proceeds from sale of property and equipment | -6,885 | -5,609 |
Net cash used by investing activities | -6,885 | -5,609 |
Cash Flows from Financing Activities: | ||
Repayments of long-term debt | -215 | -486 |
Net cash provided by financing activities | -215 | -486 |
Effect of foreign exchange rate changes on cash and cash equivalents | -818 | 153 |
Net increase in cash and cash equivalents | 3,207 | 5,020 |
Cash and cash equivalents, beginning of period | 39,533 | 30,778 |
Cash and cash equivalents, end of period | $42,740 | $35,798 |